≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other disorders of binocular movement

DOID EFO Endpoint Browser PheWeb

H7_BINOCUMOVOTH

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H51
  • Cause of death: ICD-10 — H51

2 out of 7 registries used, show all original rules.

894

4. Check minimum number of events

None

894

5. Include endpoints

925

6. Filter based on genotype QC (FinnGen only)

894

Control definitions (FinnGen only)

Control exclude
H7_OCUMUSCLE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H49-H52
Name in latin
Aliae perturbationes motus binocularis

Similar endpoints

↥

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 6549 3902 2630
Only index persons 5992 3644 2348
Unadjusted period prevalence (%)
Whole population 0.10 0.11 0.07
Only index persons 0.12 0.13 0.09
Median age at first event (years)
Whole population 26.83 27.34 25.99
Only index persons 28.28 28.58 27.82

-FinnGen-

Key figures

All Female Male
Number of individuals 894 632 262
Unadjusted period prevalence (%) 0.19 0.22 0.12
Median age at first event (years) 37.79 33.89 47.21

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
925
Matched controls
9250
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H51.1
ICD-10 Finland
Convergence insufficiency and excess
+∞
307.7
550
*
H53.3
ICD-10 Finland
Other disorders of binocular vision
86.9
228.6
121
16
H50.52
ICD-10 Finland
Exophoria
107.5
203.8
105
11
H53.2
ICD-10 Finland
Diplopia
23.2
191.1
144
73
H51.2
ICD-10 Finland
Internuclear ophthalmoplegia
+∞
149.1
139
*
H51.8
ICD-10 Finland
Other specified disorders of binocular movement
+∞
116.1
109
*
H51.9
ICD-10 Finland
Disorder of binocular movement, unspecified
+∞
86.9
82
*
H50.31
ICD-10 Finland
Intermittent exotropia
+∞
71.8
68
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.9
64.3
162
387
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.6
63.0
170
429
H50.1
ICD-10 Finland
Divergent concomitant strabismus
+∞
55.8
53
*
G35
ICD-10 Finland
Multiple sclerosis
10.2
55.4
64
67
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.9
49.3
166
490
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.1
46.2
240
930
AA1AD
NOMESCO Finland
CT of head and brain
2.9
45.4
301
1334
TAB00
NOMESCO Finland
Lumbar puncture
5.0
42.5
98
215
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
11.8
42.5
44
39
H53.1
ICD-10 Finland
Subjective visual disturbances
4.3
40.4
114
294
XA800
NOMESCO Finland
Neuropsychological investigation
5.0
39.8
91
198
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.9
39.6
130
374
109
Kela drug reimbursment
Multiple sclerosis
9.8
39.2
46
49
R51.80
ICD-10 Finland
Headache
2.8
38.4
260
1151
XCK00
NOMESCO Finland
Perimetry
5.1
37.9
83
174
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.0
36.5
192
741
H50.2
ICD-10 Finland
Vertical strabismus
187.1
35.0
36
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.8
34.4
65
119
H51.0
ICD-10 Finland
Palsy of conjugate gaze
+∞
33.5
32
*
WX704
NOMESCO Finland
Intubation
3.6
33.1
121
373
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
+∞
32.5
31
*
M03BX01
ATC
baclofen; systemic
6.9
30.4
48
73
CEC00
NOMESCO Finland
Recession of extraocular muscle
+∞
30.4
29
*
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
9.0
30.3
38
44
H50.0
ICD-10 Finland
Convergent concomitant strabismus
+∞
29.3
28
*
H52.1
ICD-10 Finland
Myopia
7.2
29.1
44
64
H52.0
ICD-10 Finland
Hypermetropia
8.9
28.5
36
42
WX725
NOMESCO Finland
Noninvasive ventilation
3.9
28.5
88
241
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.6
28.1
98
292
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.6
27.6
69
161
N03AX12
ATC
[U] gabapentin; oral
2.6
27.3
180
774
3788X
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Other disorders of binocular eye movements
+∞
26.2
25
*
H52.5
ICD-10 Finland
Disorders of accommodation
138.9
25.7
27
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
25.6
230
1139
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
23.4
25.4
36
16
H50.30
ICD-10 Finland
Intermittent esotropy
+∞
25.1
24
*
WX720
NOMESCO Finland
Own respiration
3.9
24.7
75
203
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.3
24.3
219
1083
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
23.6
243
1269
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
+∞
23.0
22
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.2
21.9
92
308
N03AG01
ATC
valproic acid; systemic, rectal
3.2
21.0
90
305
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.6
20.6
128
531
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.0
20.2
97
351
H50.8
ICD-10 Finland
Other specified strabismus
+∞
19.9
19
*
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
+∞
19.9
19
*
R42
ICD-10 Finland
Dizziness and giddiness
2.1
19.7
220
1177
L03AX13
ATC
glatiramer acetate; parenteral
18.2
19.7
30
17
R20.2
ICD-10 Finland
Paraesthesia of skin
2.9
19.2
97
360
XKC03
NOMESCO Finland
Water cystometry
5.0
19.1
42
88
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
6.0
18.5
33
57
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.6
18.5
30
47
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.5
18.4
45
103
N86
ICPC
Multiple sclerosis
16.6
18.4
29
18
UKC02
NOMESCO Finland
Cystoscopy
2.5
18.1
126
551
SPAT1301
SPAT
No procedures
1.9
17.9
306
1897
N28
ICPC
Limited function/disability (N)
6.9
17.5
27
40
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
5.4
17.1
34
65
37301
ICD-8 Finland
Strabismus, Concomitans divergens
+∞
16.7
16
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
16.5
114
495
SPAT1263
SPAT
Sampling
1.8
16.5
412
2859
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.2
16.4
68
225
K07.60
ICD-10 Finland
Snapping jaw
2.8
16.3
85
321
XLD10
NOMESCO Finland
Gynaecological examination
6.9
16.2
25
37
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
16.2
132
618
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.4
15.8
116
518
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.4
15.7
31
59
OAB47, ,
SPAT
2.8
15.5
83
318
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.1
15.4
68
234
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
2.8
15.2
82
315
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
4.0
14.9
43
112
N03AE01
ATC
clonazepam; systemic
3.2
14.9
62
206
WX702
NOMESCO Finland
Supraglottic ventilation device
2.9
14.8
70
250
H50.51
ICD-10 Finland
Esophoria
57.6
14.8
17
*
A02BC03
ATC
lansoprazole; oral
1.9
14.7
236
1419
CEC30
NOMESCO Finland
Resection of extraocular muscle
+∞
14.6
14
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
14.4
380
2648
N03AX16
ATC
[U] pregabalin
1.9
14.2
199
1142
XKD06
NOMESCO Finland
Physiologic investigation of micturition
4.7
14.1
33
73
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.3
13.9
110
507
G51.0
ICD-10 Finland
Bell palsy
4.5
13.9
34
78
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
13.8
347
2381
A04
ICPC
Weakness/tiredness general
2.0
13.6
177
990
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
+∞
13.6
13
*
H50.9
ICD-10 Finland
Strabismus, unspecified
142.0
13.5
14
*
SAA03
NOMESCO Finland
Extended examination of mouth
1.7
13.4
429
3134
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.5
13.2
84
350
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.4
13.2
33
77
L28
ICPC
Limited function/disability (L)
2.0
13.2
151
806
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
2.1
13.1
147
780
A28
ICPC
Limited function/disability NOS
2.1
13.0
128
646
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
5.7
12.9
24
43
L03AB07
ATC
interferon beta-1a; parenteral
10.7
12.8
24
23
N02BF01
ATC
gabapentin; oral
2.3
12.7
103
479
N06AX21
ATC
duloxetine; oral
2.1
12.7
130
665
SPAT1260
SPAT
Consultation of another employee
2.0
12.6
166
930
G43.9
ICD-10 Finland
Migraine, unspecified
2.3
12.6
99
455
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.2
12.5
111
537
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
12.3
255
1645
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.9
12.3
58
207
N06AA09
ATC
amitriptyline; systemic
2.5
12.3
82
350
H53.4
ICD-10 Finland
Visual field defects
5.2
12.3
25
49
N03AF01
ATC
carbamazepine; oral, rectal
3.1
12.2
52
175
XKD03
NOMESCO Finland
Urethral pressure profilometry
5.0
12.2
26
53
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.1
12.2
21
35
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
12.1
163
920
N03AX14
ATC
levetiracetam; systemic
3.9
12.0
35
92
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
11.9
231
1460
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
11.9
376
2715
N01
ICPC
Headache
1.9
11.8
169
973
XKD00
NOMESCO Finland
Uroflowmetry
2.3
11.6
96
451
N06AX11
ATC
mirtazapine; oral
1.7
11.6
315
2184
S06.0
ICD-10 Finland
Concussion
2.1
11.5
124
646
CEC60
NOMESCO Finland
Transposition of extraocular muscle with adjustable suture
+∞
11.5
11
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
11.5
88
400
G20
ICD-10 Finland
Parkinson disease
5.0
11.3
24
49
N29
ICPC
Neurological sympt/complt other
4.7
11.2
26
57
N03AF02
ATC
oxcarbazepine; oral
3.2
11.1
45
147
H46
ICD-10 Finland
Optic neuritis
8.2
11.1
24
30
N07AA02
ATC
pyridostigmine; systemic
14.1
11.0
18
13
M35.7
ICD-10 Finland
Hypermobility syndrome
4.2
10.9
29
71
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
8.4
10.8
23
28
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
4.5
10.8
26
59
N05BA01
ATC
diazepam; systemic, rectal
2.1
10.7
115
598
M50.3
ICD-10 Finland
Other cervical disc degeneration
4.4
10.6
26
60
SPAT1324
SPAT
Screening procedure
1.8
10.5
194
1205
3503
FHL
Single muscle retroposition
+∞
10.4
10
*
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
2.2
10.4
95
465
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.1
10.3
43
143
WX402
NOMESCO Finland
General anaesthesia
1.7
10.3
216
1389
Z2445
NOMESCO Finland
Psychologist
2.6
10.3
60
240
Z3229
NOMESCO Finland
Other healthcare associate professional
2.4
10.2
75
334
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
10.2
209
1336
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.7
10.2
55
212
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.3
10.1
78
355
R02
ICPC
Shortness of breath/dyspnoea
2.0
10.1
126
692
WX234
NOMESCO Finland
Paracervical blockade
2.7
10.0
55
214
M79.7
ICD-10 Finland
Fibromyalgia
3.0
9.9
43
147
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
3.7
9.9
31
86
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
12.3
9.9
17
14
KMAK, ,
NOMESCO Finland
1.6
9.9
499
3968
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
9.9
177
1089
N03AX11
ATC
topiramate; oral
3.2
9.8
38
121
C07AA05
ATC
propranolol; systemic
1.7
9.7
206
1328
R96
ICPC
Asthma
2.1
9.5
97
494
H57.1
ICD-10 Finland
Ocular pain
2.6
9.5
54
213
U07
ICPC
Urine symptom/complaint other
2.2
9.5
81
385
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
7.6
9.4
21
28
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
101.0
9.4
10
*
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.1
9.4
91
455
CEC90
NOMESCO Finland
Total transposition of extraocular muscle or muscles
+∞
9.4
9
*
2AB04, ,
NOMESCO Finland
21.9
9.4
13
6
G44.2
ICD-10 Finland
Tension-type headache
1.8
9.3
153
915
N05BA09
ATC
clobazam; oral
9.6
9.3
18
19
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
9.3
267
1860
N03AX09
ATC
lamotrigine; oral
2.3
9.2
69
310
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
9.2
444
3475
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
9.2
126
713
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
4.3
9.2
23
54
R1250
NOMESCO Finland
Evaluation of functional capability
3.6
9.1
30
86
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.3
9.1
73
338
N02AX02
ATC
tramadol; systemic, rectal
1.6
9.1
337
2486
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
9.1
214
1417
G70.0
ICD-10 Finland
Myasthenia gravis
18.8
8.9
13
7
R06.0
ICD-10 Finland
Dyspnoea
1.6
8.9
222
1491
SPAT1229
SPAT
Assessment of need for aid
2.6
8.9
52
209
F83
ICD-10 Finland
Mixed specific developmental disorders
7.3
8.8
20
28
N99
ICPC
Neurological disease other
7.3
8.8
20
28
R03BA05
ATC
fluticasone; inhalant
1.7
8.7
180
1149
P85
ICPC
Mental retardation
14.2
8.7
14
10
L12
ICPC
Hand/finger symptom/complaint
1.7
8.7
174
1102
N89
ICPC
Migraine
2.4
8.6
62
274
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
3.1
8.6
35
115
N04BB01
ATC
amantadine; oral
4.8
8.6
19
40
H02AB06
ATC
prednisolone; systemic
1.5
8.5
388
2983
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.5
8.5
53
219
H53.9
ICD-10 Finland
Visual disturbance, unspecified
2.9
8.5
40
143
B80
ICPC
Iron deficiency anaemia
3.1
8.5
35
116
XMA22
NOMESCO Finland
General examination of pregnant woman
2.1
8.5
79
389
A06AD11
ATC
lactulose; oral
2.0
8.5
101
545
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
3.9
8.5
24
62
F95
ICPC
Strabismus
90.9
8.4
9
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.9
8.4
38
133
164
Kela drug reimbursment
Fingolimod
12.9
8.4
14
11
N06AB04
ATC
citalopram; systemic
1.7
8.4
175
1120
WX400
NOMESCO Finland
Inhalation anesthesy
2.5
8.4
51
209
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
8.3
113
636
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
+∞
8.3
8
*
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
8.3
214
1444
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.4
8.3
58
253
G04BD09
ATC
trospium; oral
4.1
8.3
22
54
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
8.3
298
2175
A45
ICPC
General and Unspecified, Observ/health educat/advice/diet
3.4
8.3
29
87
R03CC03
ATC
terbutaline; systemic
2.9
8.3
39
140
K90
ICPC
Stroke/cerebrovascular accident
4.3
8.2
21
50
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.1
8.2
82
415
Z3231
NOMESCO Finland
Registered nurse
1.6
8.1
235
1631
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
8.1
111
627
4AA23, ,
NOMESCO Finland
33.7
8.1
10
*
A01
ICPC
Pain general/multiple sites
2.0
8.1
96
517
R52.2
ICD-10 Finland
Other chronic pain
2.7
8.1
42
159
G04BD12
ATC
mirabegron; oral
2.0
8.1
84
432
M03AX01
ATC
botulinum toxin; parenteral
3.7
8.1
25
69
SPAT1097
SPAT
Recording of ECG
1.9
8.0
103
569
H52.3
ICD-10 Finland
Anisometropia and aniseikonia
22.2
8.0
11
5
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
22.2
8.0
11
5
O28.8
ICD-10 Finland
Other abnormal findings on antenatal screening of mother
3.9
8.0
23
60
R4110
NOMESCO Finland
Physiotherapy
1.6
8.0
226
1561
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.8
7.9
24
65
R41.3
ICD-10 Finland
Other amnesia
3.6
7.9
25
70
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
7.9
94
507
-1, ,
NOMESCO Finland
1.5
7.9
347
2639
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.1
7.9
74
366
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.4
7.9
53
228
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.8
7.8
23
61
JAETT, ,
NOMESCO Finland
10.9
7.8
14
13
B01AC07
ATC
dipyridamole; systemic
3.7
7.8
24
66
A02BC01
ATC
omeprazole; systemic
1.6
7.7
218
1502
L04AA27
ATC
[U] fingolimod
15.2
7.7
12
8
G46.3*I67.9
ICD-10 Finland
Brain stem stroke syndrome (I60-I67+)
45.4
7.7
9
*
A02BC02
ATC
pantoprazole; systemic
1.5
7.7
552
4620
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
3.8
7.7
23
62
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
7.6
272
1975
G81.9
ICD-10 Finland
Hemiplegia, unspecified
6.8
7.6
18
27
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.8
7.6
124
739
A78
ICPC
Infectious disease other/NOS
3.0
7.6
33
113
H54.7
ICD-10 Finland
Unspecified visual loss
12.0
7.6
13
11
CE2W4
NOMESCO Finland
Eye movement mapping
25.2
7.6
10
*
108
Kela drug reimbursment
Myasthenia gravis
25.2
7.6
10
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
7.6
172
1123
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.9
7.5
34
119
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.7
7.4
169
1103
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
80.7
7.4
8
*
C03CA01
ATC
furosemide; systemic
1.7
7.4
165
1073
A03FA02
ATC
cisapride; oral, rectal
2.3
7.3
55
248
F45.8
ICD-10 Finland
Other somatoform disorders
1.9
7.3
89
483
G43.3
ICD-10 Finland
Complicated migraine
3.2
7.3
28
89
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
3.5
7.3
24
69
H47.7
ICD-10 Finland
Disorder of visual pathways, unspecified
+∞
7.3
7
*
MBA20
NOMESCO Finland
Expression of placenta
5.9
7.2
19
33
H52.2
ICD-10 Finland
Astigmatism
5.9
7.2
19
33
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.6
7.2
23
65
M01AB16
ATC
aceclofenac; oral
3.3
7.1
26
80
N02CC06
ATC
eletriptan; oral
2.4
7.1
47
200
M54.5
ICD-10 Finland
Low back pain
1.5
7.1
338
2596
N06AB10
ATC
escitalopram; oral
1.6
7.1
217
1519
H53.0
ICD-10 Finland
Amblyopia ex anopsia
8.0
7.1
15
19
TKC22
NOMESCO Finland
Catheterisation instruction
4.1
7.1
19
47
R03AC02
ATC
salbutamol; inhalant
1.5
7.1
510
4240
-45
ICPC
Observ/health educat/advice/diet
3.0
7.1
31
107
A02BA02
ATC
ranitidine; systemic
1.7
7.1
133
826
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
10.1
7.0
13
13
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.4
7.0
47
202
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.1
7.0
29
97
A02BC05
ATC
esomeprazole; systemic
1.5
7.0
322
2459
N05CF01
ATC
zopiclone; oral
1.5
7.0
236
1691
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.5
6.9
19
35
C07AB07
ATC
bisoprolol; oral
1.5
6.9
313
2379
N05CD07
ATC
temazepam; oral
2.0
6.9
71
363
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
6.9
165
1090
R3120
NOMESCO Finland
Training in mobility skills
13.9
6.9
11
8
R53
ICD-10 Finland
Malaise and fatigue
1.5
6.9
240
1729
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.5
6.9
43
179
J01DA09
ATC
[U] cefadroxil
1.5
6.9
225
1600
M48.0
ICD-10 Finland
Spinal stenosis
1.9
6.9
82
443
N02CC03
ATC
zolmitriptan; nasal, oral
2.1
6.8
65
323
R13
ICD-10 Finland
Dysphagia
2.1
6.8
61
296
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
3.8
6.8
20
53
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
6.8
75
394
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.4
6.8
47
205
R50.9
ICD-10 Finland
Fever, unspecified
1.7
6.8
144
923
RS222, ,
NOMESCO Finland
4.3
6.8
17
40
H50.50
ICD-10 Finland
Alternating hyperphoria
40.4
6.8
8
*
RS142, ,
NOMESCO Finland
16.8
6.8
10
6
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
16.8
6.8
10
6
N03AX22
ATC
perampanel; oral
22.7
6.7
9
*
183
Kela drug reimbursment
Lamotrigin and topiramate
5.5
6.6
18
33
CS494
NOMESCO Finland
Other visual field testing
3.5
6.6
22
64
353
Kela drug reimbursment
Cladribine and fingolimod
12.4
6.6
11
9
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
6.6
167
1119
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
8.8
6.6
13
15
N05AH04
ATC
quetiapine; oral
1.6
6.5
177
1204
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.0
6.5
65
329
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.9
6.5
84
466
SAA04
NOMESCO Finland
Special examination of mouth
2.1
6.5
59
289
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
3.4
6.4
22
65
181
Kela drug reimbursment
Retigabine and vigabatrin
70.3
6.4
7
*
N02CC05
ATC
almotriptan; oral
2.3
6.4
49
223
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
7.5
6.4
14
19
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
6.4
116
712
H02.2
ICD-10 Finland
Lagophthalmos
14.4
6.4
10
7
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
14.4
6.4
10
7
X01
ICPC
Genital pain female
4.1
6.4
17
42
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.7
6.4
34
131
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
6.6
6.3
15
23
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
6.3
52
244
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
6.3
496
4153
XQ855, ,
SPAT
5.2
6.3
18
35
SPAT1050
SPAT
Extensive neurological examination
3.2
6.3
24
76
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
9.3
6.3
12
13
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.1
6.3
55
265
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.0
6.3
65
334
L03AB08
ATC
interferon beta-1b; parenteral
18.2
6.3
9
5
3789X
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Unspecified disorder of eye movements
+∞
6.3
6
*
0148, ,
NOMESCO Finland
+∞
6.3
6
*
G80.8
ICD-10 Finland
Other cerebral palsy
+∞
6.3
6
*
3507
FHL
Retroposition and resection
+∞
6.3
6
*
CEW99
NOMESCO Finland
Other operation on extraocular muscle
+∞
6.3
6
*
J01DA01
ATC
[U] cefalexin
1.4
6.3
516
4357
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
26.9
6.2
8
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
6.2
47
213
J01EA01
ATC
trimethoprim; systemic
1.5
6.2
216
1551
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.8
6.2
87
495
N87
ICPC
Parkinsonism
6.3
6.2
15
24
HAMTE, ,
NOMESCO Finland
5.4
6.2
17
32
PA7BD
NOMESCO Finland
CT angiography of neck and brain
5.8
6.2
16
28
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
6.1
178
1230
SPAT1101
SPAT
Orthostatic test
2.8
6.1
29
105
ZXA10
NOMESCO Finland
Bilateral
1.6
6.0
133
860
N05BA04
ATC
oxazepam; oral
1.5
6.0
221
1604
N05CD08
ATC
midazolam; nasal, systemic
3.5
6.0
20
58
-, ,
ICD-10 Finland
3.5
6.0
20
58
L04AX01
ATC
azathioprine; systemic
2.4
6.0
38
159
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.9
6.0
75
411
F05
ICPC
Visual disturbance other
2.6
6.0
34
135

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Neurology
13 [38004458]
1.3e+00
2.2e+00
3.2e+00
—
3.5e+00
2.8e+00
1.7e+00
cases:18.09%
controls:5.50%
cases:20.80%
controls:2.79%
cases:10.73%
controls:0.49%
—
—
cases:13.40%
controls:0.47%
cases:27.36%
controls:2.34%
cases:29.19%
controls:7.08%
163
492
738
8452
188
250
716
8720
97
44
807
8926
—
121
42
782
8924
243
206
645
8615
242
583
587
7655
Ophthalmology
18 [38004463]
7.7e-01
2.0e+00
2.9e+00
—
4.5e+00
3.2e+00
8.7e-01
cases:18.98%
controls:9.75%
cases:26.11%
controls:4.67%
cases:11.39%
controls:0.68%
—
—
cases:39.87%
controls:0.72%
cases:58.00%
controls:5.21%
cases:28.23%
controls:14.13%
171
872
730
8072
236
419
668
8551
103
61
801
8909
—
360
65
543
8901
515
460
373
8361
234
1164
595
7074
Multiple sclerosis
G35 [45571794]
3.2e+00
3.5e+00
—
1.0e+50
—
3.5e+00
3.5e+00
cases:3.00%
controls:0.12%
cases:3.10%
controls:0.10%
—
—
cases:1.77%
controls:0.00%
—
—
cases:5.41%
controls:0.17%
cases:6.03%
controls:0.19%
27
11
874
8933
28
9
876
8961
—
16
0
888
8970
—
48
15
840
8806
50
16
779
8222
Outpatient Visit
OP [9202]
4.1e-01
8.0e-01
1.1e+00
5.9e+00
2.4e+00
1.7e+00
6.7e-01
cases:66.48%
controls:56.79%
cases:60.29%
controls:40.61%
cases:24.89%
controls:10.12%
cases:65.71%
controls:0.50%
cases:53.49%
controls:9.41%
cases:78.94%
controls:41.55%
cases:80.82%
controls:68.28%
599
5079
302
3865
545
3643
359
5327
225
908
679
8062
594
45
310
8925
483
844
420
8122
701
3665
187
5156
670
5625
159
2613
Diplopia
H53.2 [45576792]
3.1e+00
4.1e+00
—
1.0e+50
—
—
3.9e+00
cases:2.33%
controls:0.11%
cases:3.98%
controls:0.07%
—
—
cases:2.99%
controls:0.00%
—
—
—
—
cases:3.38%
controls:0.07%
21
10
880
8934
36
6
868
8964
—
27
0
877
8970
—
—
28
6
801
8232
Parkinson disease
G20 [45538098]
2.0e+00
2.4e+00
2.6e+00
—
—
2.4e+00
1.5e+00
cases:1.66%
controls:0.22%
cases:1.66%
controls:0.16%
cases:0.88%
controls:0.07%
—
—
—
—
cases:1.80%
controls:0.16%
cases:1.45%
controls:0.33%
15
20
886
8924
15
14
889
8956
8
6
896
8964
—
—
16
14
872
8807
12
27
817
8211
Paediatric neurology
421 [44777781]
9.5e-01
1.6e+00
2.1e+00
—
2.5e+00
1.9e+00
1.6e+00
cases:2.66%
controls:1.05%
cases:3.21%
controls:0.64%
cases:1.11%
controls:0.13%
—
—
cases:1.11%
controls:0.09%
cases:2.82%
controls:0.43%
cases:3.62%
controls:0.78%
24
94
877
8850
29
57
875
8913
10
12
894
8958
—
10
8
893
8958
25
38
863
8783
30
64
799
8174
levodopa and decarboxylase inhibitor; oral
N04BA02 [21604465]
2.2e+00
2.2e+00
1.8e+00
—
2.0e+00
2.3e+00
1.6e+00
cases:1.78%
controls:0.20%
cases:1.77%
controls:0.20%
cases:0.77%
controls:0.12%
—
—
cases:0.55%
controls:0.08%
cases:2.36%
controls:0.24%
cases:1.69%
controls:0.34%
16
18
885
8926
16
18
888
8952
7
11
897
8959
—
5
7
898
8959
21
21
867
8800
14
28
815
8210
Inpatient Hospital
21 [8717]
3.0e-01
8.4e-01
1.6e+00
4.6e+00
1.2e+00
7.7e-01
4.4e-01
cases:37.29%
controls:30.68%
cases:20.69%
controls:10.13%
cases:6.08%
controls:1.33%
cases:6.53%
controls:0.07%
cases:4.54%
controls:1.35%
cases:19.59%
controls:10.10%
cases:36.07%
controls:26.61%
336
2744
565
6200
187
909
717
8061
55
119
849
8851
59
6
845
8964
41
121
862
8845
174
891
714
7930
299
2192
530
6046
Physiotherapy
R4110 [2001310233]
1.0e+00
1.7e+00
2.4e+00
—
2.1e+00
1.5e+00
9.5e-01
cases:6.77%
controls:2.58%
cases:5.20%
controls:0.98%
cases:1.44%
controls:0.13%
—
—
cases:1.33%
controls:0.17%
cases:3.60%
controls:0.83%
cases:6.15%
controls:2.48%
61
231
840
8713
47
88
857
8882
13
12
891
8958
—
12
15
891
8951
32
73
856
8748
51
204
778
8034
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
1.2e+00
1.6e+00
1.8e+00
—
1.5e+00
1.5e+00
1.5e+00
cases:2.44%
controls:0.73%
cases:2.43%
controls:0.51%
cases:0.88%
controls:0.14%
—
—
cases:1.00%
controls:0.22%
cases:2.48%
controls:0.57%
cases:3.74%
controls:0.83%
22
65
879
8879
22
46
882
8924
8
13
896
8957
—
9
20
894
8946
22
50
866
8771
31
68
798
8170
Neurosurgery
14 [38004459]
1.3e+00
1.6e+00
2.8e+00
—
2.1e+00
1.9e+00
1.4e+00
cases:5.11%
controls:1.44%
cases:3.21%
controls:0.64%
cases:1.11%
controls:0.07%
—
—
cases:0.55%
controls:0.07%
cases:3.49%
controls:0.56%
cases:5.55%
controls:1.47%
46
129
855
8815
29
57
875
8913
10
6
894
8964
—
5
6
898
8960
31
49
857
8772
46
121
783
8117
Neuropsychological investigation
XA800 [2001300412]
1.8e+00
2.6e+00
—
—
—
3.0e+00
1.6e+00
cases:2.00%
controls:0.34%
cases:1.33%
controls:0.10%
—
—
—
—
—
—
cases:1.58%
controls:0.08%
cases:1.81%
controls:0.38%
18
30
883
8914
12
9
892
8961
—
—
—
14
7
874
8814
15
31
814
8207
Dizziness and giddiness
R42 [45568132]
1.1e+00
1.9e+00
3.5e+00
1.0e+50
—
1.5e+00
9.3e-01
cases:4.33%
controls:1.54%
cases:3.87%
controls:0.61%
cases:1.88%
controls:0.06%
cases:1.11%
controls:0.00%
—
—
cases:2.48%
controls:0.56%
cases:4.58%
controls:1.86%
39
138
862
8806
35
55
869
8915
17
5
887
8965
10
0
894
8970
—
22
49
866
8772
38
153
791
8085
Subjective visual disturbances
H53.1 [45557467]
1.5e+00
3.1e+00
1.0e+50
1.0e+50
1.0e+50
2.7e+00
1.5e+00
cases:1.33%
controls:0.31%
cases:2.43%
controls:0.11%
cases:1.00%
controls:0.00%
cases:1.11%
controls:0.00%
cases:0.89%
controls:0.00%
cases:2.25%
controls:0.15%
cases:2.29%
controls:0.50%
12
28
889
8916
22
10
882
8960
9
0
895
8970
10
0
894
8970
8
0
895
8966
20
13
868
8808
19
41
810
8197
Cerebral infarction, unspecified
I63.9 [45596216]
1.2e+00
2.5e+00
—
1.0e+50
2.9e+00
2.1e+00
1.3e+00
cases:1.22%
controls:0.37%
cases:2.10%
controls:0.18%
—
—
cases:1.88%
controls:0.00%
cases:1.00%
controls:0.06%
cases:1.69%
controls:0.22%
cases:2.41%
controls:0.67%
11
33
890
8911
19
16
885
8954
—
17
0
887
8970
9
5
894
8961
15
19
873
8802
20
55
809
8183
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
1.5e+00
2.4e+00
—
1.0e+50
—
2.7e+00
2.2e+00
cases:2.66%
controls:0.63%
cases:2.54%
controls:0.25%
—
—
cases:1.88%
controls:0.00%
—
—
cases:2.25%
controls:0.16%
cases:4.10%
controls:0.49%
24
56
877
8888
23
22
881
8948
—
17
0
887
8970
—
20
14
868
8807
34
40
795
8198
Physical Medicine And Rehabilitation
25 [38004468]
9.7e-01
1.2e+00
2.1e+00
—
2.1e+00
1.4e+00
9.9e-01
cases:9.66%
controls:3.90%
cases:4.54%
controls:1.44%
cases:1.55%
controls:0.20%
—
—
cases:1.88%
controls:0.25%
cases:5.41%
controls:1.38%
cases:11.58%
controls:4.65%
87
349
814
8595
41
129
863
8841
14
18
890
8952
—
17
22
886
8944
48
122
840
8699
96
383
733
7855
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
9.5e-01
1.3e+00
—
—
3.3e+00
1.8e+00
1.2e+00
cases:1.78%
controls:0.69%
cases:1.44%
controls:0.39%
—
—
—
—
cases:1.44%
controls:0.06%
cases:2.03%
controls:0.34%
cases:2.77%
controls:0.86%
16
62
885
8882
13
35
891
8935
—
—
13
5
890
8961
18
30
870
8791
23
71
806
8167
Headache
R51.80 [2000503603]
1.1e+00
2.3e+00
—
1.0e+50
2.5e+00
1.9e+00
7.2e-01
cases:4.77%
controls:1.60%
cases:3.65%
controls:0.39%
—
—
cases:1.55%
controls:0.00%
cases:0.66%
controls:0.06%
cases:3.04%
controls:0.46%
cases:4.34%
controls:2.16%
43
143
858
8801
33
35
871
8935
—
14
0
890
8970
6
5
897
8961
27
41
861
8780
36
178
793
8060
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
1.7e+00
2.6e+00
—
1.0e+50
—
2.6e+00
1.6e+00
cases:2.44%
controls:0.46%
cases:2.54%
controls:0.20%
—
—
cases:1.00%
controls:0.00%
—
—
cases:1.35%
controls:0.10%
cases:2.77%
controls:0.59%
22
41
879
8903
23
18
881
8952
—
9
0
895
8970
—
12
9
876
8812
23
49
806
8189
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.6e-01
6.2e-01
1.2e+00
3.7e+00
1.7e+00
5.3e-01
3.2e-01
cases:18.20%
controls:14.59%
cases:16.59%
controls:9.69%
cases:5.75%
controls:1.73%
cases:3.98%
controls:0.10%
cases:7.64%
controls:1.48%
cases:15.54%
controls:9.77%
cases:26.42%
controls:20.62%
164
1305
737
7639
150
869
754
8101
52
155
852
8815
36
9
868
8961
69
133
834
8833
138
862
750
7959
219
1699
610
6539
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
7.9e-01
1.3e+00
1.7e+00
—
2.3e+00
1.1e+00
7.0e-01
cases:5.44%
controls:2.54%
cases:4.98%
controls:1.37%
cases:1.22%
controls:0.22%
—
—
cases:1.33%
controls:0.13%
cases:3.60%
controls:1.19%
cases:5.79%
controls:2.95%
49
227
852
8717
45
123
859
8847
11
20
893
8950
—
12
12
891
8954
32
105
856
8716
48
243
781
7995
Other investigative procedure of eye
XCW99 [2001301491]
1.3e+00
2.7e+00
—
1.0e+50
—
2.9e+00
9.9e-01
cases:2.89%
controls:0.77%
cases:2.54%
controls:0.18%
—
—
cases:6.53%
controls:0.00%
—
—
cases:4.39%
controls:0.25%
cases:2.41%
controls:0.91%
26
69
875
8875
23
16
881
8954
—
59
0
845
8970
—
39
22
849
8799
20
75
809
8163
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
1.5e+00
2.4e+00
—
—
—
2.3e+00
1.7e+00
cases:2.11%
controls:0.49%
cases:1.99%
controls:0.18%
—
—
—
—
—
—
cases:1.91%
controls:0.20%
cases:3.50%
controls:0.64%
19
44
882
8900
18
16
886
8954
—
—
—
17
18
871
8803
29
53
800
8185
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
8.3e-01
1.7e+00
—
1.0e+50
3.0e+00
1.3e+00
9.7e-01
cases:4.66%
controls:2.09%
cases:5.31%
controls:0.97%
—
—
cases:1.99%
controls:0.00%
cases:2.44%
controls:0.12%
cases:3.15%
controls:0.87%
cases:8.44%
controls:3.39%
42
187
859
8757
48
87
856
8883
—
18
0
886
8970
22
11
881
8955
28
77
860
8744
70
279
759
7959
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2.1e-01
5.4e-01
1.2e+00
3.8e+00
1.5e+00
5.2e-01
3.2e-01
cases:17.76%
controls:14.85%
cases:17.59%
controls:11.09%
cases:5.53%
controls:1.76%
cases:4.31%
controls:0.10%
cases:7.64%
controls:1.84%
cases:17.12%
controls:10.94%
cases:28.11%
controls:22.06%
160
1328
741
7616
159
995
745
7975
50
158
854
8812
39
9
865
8961
69
165
834
8801
152
965
736
7856
233
1817
596
6421
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
1.4e+00
1.6e+00
2.2e+00
—
—
1.5e+00
1.2e+00
cases:2.22%
controls:0.57%
cases:1.55%
controls:0.32%
cases:0.77%
controls:0.09%
—
—
—
—
cases:1.80%
controls:0.40%
cases:3.50%
controls:1.09%
20
51
881
8893
14
29
890
8941
7
8
897
8962
—
—
16
35
872
8786
29
90
800
8148
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
1.8e+00
3.4e+00
—
—
1.0e+50
—
2.6e+00
cases:0.89%
controls:0.15%
cases:1.66%
controls:0.06%
—
—
—
—
cases:1.22%
controls:0.00%
—
—
cases:1.69%
controls:0.13%
8
13
893
8931
15
5
889
8965
—
—
11
0
892
8966
—
14
11
815
8227
Examination of eyes and vision
Z01.0 [45566391]
3.3e-01
1.5e+00
3.0e+00
1.0e+50
2.0e+00
1.3e+00
3.0e-01
cases:2.77%
controls:2.00%
cases:3.65%
controls:0.88%
cases:1.77%
controls:0.09%
cases:1.11%
controls:0.00%
cases:1.00%
controls:0.13%
cases:3.83%
controls:1.07%
cases:4.10%
controls:3.08%
25
179
876
8765
33
79
871
8891
16
8
888
8962
10
0
894
8970
9
12
894
8954
34
94
854
8727
34
254
795
7984
Lumbar puncture
TAB00 [2001300538]
1.6e+00
2.4e+00
—
1.0e+50
—
2.1e+00
1.7e+00
cases:1.78%
controls:0.38%
cases:1.55%
controls:0.14%
—
—
cases:0.88%
controls:0.00%
—
—
cases:1.13%
controls:0.14%
cases:1.33%
controls:0.24%
16
34
885
8910
14
13
890
8957
—
8
0
896
8970
—
10
12
878
8809
11
20
818
8218
Office Visit
OMOP4822458 [581477]
3.5e-01
7.6e-01
9.7e-01
4.4e+00
1.5e+00
7.2e-01
3.8e-01
cases:10.88%
controls:7.93%
cases:6.97%
controls:3.39%
cases:1.11%
controls:0.42%
cases:4.20%
controls:0.06%
cases:2.44%
controls:0.54%
cases:6.76%
controls:3.41%
cases:12.30%
controls:8.75%
98
709
803
8235
63
304
841
8666
10
38
894
8932
38
5
866
8965
22
48
881
8918
60
301
828
8520
102
721
727
7517
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
2.1e-01
8.4e-01
1.4e+00
2.3e+00
1.7e+00
8.4e-01
5.4e-01
cases:8.99%
controls:7.38%
cases:7.74%
controls:3.50%
cases:1.88%
controls:0.46%
cases:0.66%
controls:0.07%
cases:2.88%
controls:0.54%
cases:8.67%
controls:3.92%
cases:16.16%
controls:10.14%
81
660
820
8284
70
314
834
8656
17
41
887
8929
6
6
898
8964
26
48
877
8918
77
346
811
8475
134
835
695
7403
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2.0e-01
5.2e-01
1.2e+00
3.7e+00
1.4e+00
5.1e-01
3.2e-01
cases:17.65%
controls:14.92%
cases:17.48%
controls:11.15%
cases:5.53%
controls:1.77%
cases:4.20%
controls:0.11%
cases:7.64%
controls:1.91%
cases:17.23%
controls:11.10%
cases:28.23%
controls:22.17%
159
1334
742
7610
158
1000
746
7970
50
159
854
8811
38
10
866
8960
69
171
834
8795
153
979
735
7842
234
1826
595
6412
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
1.7e+00
3.4e+00
—
—
1.0e+50
—
2.5e+00
cases:1.00%
controls:0.19%
cases:1.88%
controls:0.07%
—
—
—
—
cases:1.55%
controls:0.00%
—
—
cases:1.81%
controls:0.16%
9
17
892
8927
17
6
887
8964
—
—
14
0
889
8966
—
15
13
814
8225
levetiracetam; oral, parenteral
N03AX14 [21604436]
1.3e+00
2.9e+00
—
—
—
2.2e+00
2.2e+00
cases:0.55%
controls:0.15%
cases:1.22%
controls:0.07%
—
—
—
—
—
—
cases:1.01%
controls:0.11%
cases:1.69%
controls:0.19%
5
13
896
8931
11
6
893
8964
—
—
—
9
10
879
8811
14
16
815
8222
Thorax X-ray examination
GD1AA [2001303617]
3.5e-01
1.1e+00
2.2e+00
1.0e+50
2.1e+00
1.0e+00
8.1e-01
cases:5.66%
controls:4.06%
cases:4.09%
controls:1.43%
cases:1.44%
controls:0.16%
cases:1.33%
controls:0.00%
cases:0.89%
controls:0.11%
cases:3.94%
controls:1.44%
cases:9.41%
controls:4.42%
51
363
850
8581
37
128
867
8842
13
14
891
8956
12
0
892
8970
8
10
895
8956
35
127
853
8694
78
364
751
7874
baclofen; oral, parenteral
M03BX01 [21604115]
1.9e+00
2.9e+00
—
—
—
—
2.4e+00
cases:1.00%
controls:0.16%
cases:1.00%
controls:0.06%
—
—
—
—
—
—
—
—
cases:1.69%
controls:0.16%
9
14
892
8930
9
5
895
8965
—
—
—
—
14
13
815
8225
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
1.6e+00
3.2e+00
—
—
1.0e+50
—
2.1e+00
cases:1.00%
controls:0.20%
cases:1.88%
controls:0.08%
—
—
—
—
cases:1.33%
controls:0.00%
—
—
cases:1.33%
controls:0.16%
9
18
892
8926
17
7
887
8963
—
—
12
0
891
8966
—
11
13
818
8225
CBC panel - Blood by Automated count
58410-2 [40761511]
1.7e-01
4.7e-01
9.1e-01
3.9e+00
1.2e+00
4.3e-01
1.4e-01
cases:18.65%
controls:16.14%
cases:16.04%
controls:10.66%
cases:4.20%
controls:1.73%
cases:3.65%
controls:0.08%
cases:5.98%
controls:1.81%
cases:15.32%
controls:10.50%
cases:24.61%
controls:22.13%
168
1444
733
7500
145
956
759
8014
38
155
866
8815
33
7
871
8963
54
162
849
8804
136
926
752
7895
204
1823
625
6415
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.6e-01
4.6e-01
1.1e+00
3.5e+00
1.4e+00
4.6e-01
2.6e-01
cases:18.87%
controls:16.57%
cases:19.58%
controls:13.27%
cases:7.30%
controls:2.52%
cases:4.31%
controls:0.13%
cases:8.97%
controls:2.42%
cases:19.59%
controls:13.29%
cases:29.92%
controls:24.74%
170
1482
731
7462
177
1190
727
7780
66
226
838
8744
39
12
865
8958
81
217
822
8749
174
1172
714
7649
248
2038
581
6200
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
1.2e+00
2.2e+00
—
—
—
1.9e+00
1.5e+00
cases:2.00%
controls:0.58%
cases:1.44%
controls:0.16%
—
—
—
—
—
—
cases:1.24%
controls:0.19%
cases:2.65%
controls:0.61%
18
52
883
8892
13
14
891
8956
—
—
—
11
17
877
8804
22
50
807
8188
Psychiatry
26 [38004469]
8.4e-01
1.2e+00
1.2e+00
—
1.3e+00
1.3e+00
9.2e-01
cases:9.66%
controls:4.42%
cases:7.52%
controls:2.31%
cases:3.32%
controls:1.00%
—
—
cases:3.21%
controls:0.94%
cases:8.00%
controls:2.22%
cases:12.42%
controls:5.34%
87
395
814
8549
68
207
836
8763
30
90
874
8880
—
29
84
874
8882
71
196
817
8625
103
440
726
7798
gabapentin; oral
N02BF01 [955005]
1.3e+00
1.4e+00
1.0e+00
—
1.5e+00
1.6e+00
1.1e+00
cases:4.44%
controls:1.25%
cases:2.99%
controls:0.77%
cases:0.77%
controls:0.28%
—
—
cases:1.11%
controls:0.26%
cases:3.60%
controls:0.78%
cases:5.19%
controls:1.78%
40
112
861
8832
27
69
877
8901
7
25
897
8945
—
10
23
893
8943
32
69
856
8752
43
147
786
8091
solifenacin; oral
G04BD08 [21602641]
1.5e+00
1.9e+00
—
—
—
1.8e+00
1.6e+00
cases:1.33%
controls:0.30%
cases:0.88%
controls:0.13%
—
—
—
—
—
—
cases:0.79%
controls:0.14%
cases:1.93%
controls:0.40%
12
27
889
8917
8
12
896
8958
—
—
—
7
12
881
8809
16
33
813
8205
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
9.2e-01
1.7e+00
1.9e+00
—
—
1.3e+00
8.2e-01
cases:3.11%
controls:1.26%
cases:3.54%
controls:0.64%
cases:0.77%
controls:0.11%
—
—
—
—
cases:1.69%
controls:0.48%
cases:3.26%
controls:1.46%
28
113
873
8831
32
57
872
8913
7
10
897
8960
—
—
15
42
873
8779
27
120
802
8118
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
2.1e-01
4.2e-01
1.2e+00
3.2e+00
1.4e+00
4.2e-01
2.7e-01
cases:12.54%
controls:10.45%
cases:12.72%
controls:8.75%
cases:5.09%
controls:1.57%
cases:2.77%
controls:0.11%
cases:6.20%
controls:1.56%
cases:13.06%
controls:9.01%
cases:21.83%
controls:17.54%
113
935
788
8009
115
785
789
8185
46
141
858
8829
25
10
879
8960
56
140
847
8826
116
795
772
8026
181
1445
648
6793
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
6.4e-01
1.4e+00
—
—
2.4e+00
1.4e+00
8.5e-01
cases:4.11%
controls:2.20%
cases:2.21%
controls:0.57%
—
—
—
—
cases:1.00%
controls:0.09%
cases:2.70%
controls:0.67%
cases:4.83%
controls:2.12%
37
197
864
8747
20
51
884
8919
—
—
9
8
894
8958
24
59
864
8762
40
175
789
8063
carisoprodol; oral
M03BA02 [21604094]
1.8e+00
2.6e+00
—
—
—
2.3e+00
2.2e+00
cases:0.89%
controls:0.15%
cases:0.77%
controls:0.06%
—
—
—
—
—
—
cases:0.56%
controls:0.06%
cases:1.09%
controls:0.12%
8
13
893
8931
7
5
897
8965
—
—
—
5
5
883
8816
9
10
820
8228
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
1.1e+00
2.0e+00
—
—
—
1.9e+00
1.6e+00
cases:1.66%
controls:0.56%
cases:1.00%
controls:0.13%
—
—
—
—
—
—
cases:1.01%
controls:0.16%
cases:1.81%
controls:0.38%
15
50
886
8894
9
12
895
8958
—
—
—
9
14
879
8807
15
31
814
8207
Perimetry
XCK00 [2001301380]
1.1e+00
2.1e+00
—
—
—
2.1e+00
1.2e+00
cases:1.44%
controls:0.49%
cases:1.11%
controls:0.13%
—
—
—
—
—
—
cases:1.24%
controls:0.15%
cases:1.57%
controls:0.49%
13
44
888
8900
10
12
894
8958
—
—
—
11
13
877
8808
13
40
816
8198
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
2.6e-01
4.3e-01
7.8e-01
3.3e+00
1.2e+00
4.9e-01
3.1e-01
cases:16.20%
controls:12.92%
cases:15.15%
controls:10.39%
cases:4.31%
controls:2.03%
cases:3.43%
controls:0.13%
cases:6.76%
controls:2.13%
cases:15.43%
controls:10.06%
cases:23.88%
controls:18.77%
146
1156
755
7788
137
932
767
8038
39
182
865
8788
31
12
873
8958
61
191
842
8775
137
887
751
7934
198
1546
631
6692
Emergency Room Visit
ER [9203]
4.1e-01
1.1e+00
2.0e+00
—
1.4e+00
8.2e-01
6.4e-01
cases:35.07%
controls:26.34%
cases:24.12%
controls:9.75%
cases:7.41%
controls:1.07%
—
—
cases:4.76%
controls:1.27%
cases:19.48%
controls:9.60%
cases:42.94%
controls:28.37%
316
2356
585
6588
218
875
686
8095
67
96
837
8874
—
43
114
860
8852
173
847
715
7974
356
2337
473
5901
General Practice
1 [38004446]
4.2e-01
9.6e-01
1.4e+00
—
1.8e+00
8.7e-01
7.7e-01
cases:11.54%
controls:7.92%
cases:7.85%
controls:3.17%
cases:1.88%
controls:0.46%
—
—
cases:2.33%
controls:0.38%
cases:6.98%
controls:3.04%
cases:17.61%
controls:9.03%
104
708
797
8236
71
284
833
8686
17
41
887
8929
—
21
34
882
8932
62
268
826
8553
146
744
683
7494
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.2e-01
4.7e-01
8.5e-01
3.3e+00
1.2e+00
4.7e-01
1.2e-01
cases:17.09%
controls:15.44%
cases:17.37%
controls:11.65%
cases:5.09%
controls:2.24%
cases:3.21%
controls:0.12%
cases:7.20%
controls:2.38%
cases:16.78%
controls:11.14%
cases:24.13%
controls:21.98%
154
1381
747
7563
157
1045
747
7925
46
201
858
8769
29
11
875
8959
65
213
838
8753
149
983
739
7838
200
1811
629
6427
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.1e-01
3.6e-01
8.7e-01
3.3e+00
1.2e+00
4.0e-01
1.5e-01
cases:21.20%
controls:19.42%
cases:21.46%
controls:15.99%
cases:7.19%
controls:3.15%
cases:4.20%
controls:0.16%
cases:9.63%
controls:3.25%
cases:21.85%
controls:15.75%
cases:31.60%
controls:28.40%
191
1737
710
7207
194
1434
710
7536
65
283
839
8687
38
14
866
8956
87
291
816
8675
194
1389
694
7432
262
2340
567
5898
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.1e-01
3.6e-01
8.7e-01
3.3e+00
1.2e+00
4.0e-01
1.6e-01
cases:21.20%
controls:19.42%
cases:21.46%
controls:15.98%
cases:7.19%
controls:3.14%
cases:4.20%
controls:0.16%
cases:9.52%
controls:3.22%
cases:21.73%
controls:15.74%
cases:31.72%
controls:28.37%
191
1737
710
7207
194
1433
710
7537
65
282
839
8688
38
14
866
8956
86
289
817
8677
193
1388
695
7433
263
2337
566
5901
MCH [Entitic mass]
28539-5 [3035941]
1.1e-01
3.6e-01
8.7e-01
3.3e+00
1.2e+00
4.0e-01
1.5e-01
cases:21.20%
controls:19.40%
cases:21.46%
controls:15.95%
cases:7.19%
controls:3.15%
cases:4.20%
controls:0.16%
cases:9.52%
controls:3.22%
cases:21.73%
controls:15.75%
cases:31.60%
controls:28.37%
191
1735
710
7209
194
1431
710
7539
65
283
839
8687
38
14
866
8956
86
289
817
8677
193
1389
695
7432
262
2337
567
5901
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.1e-01
3.6e-01
8.7e-01
3.3e+00
1.2e+00
4.0e-01
1.6e-01
cases:21.20%
controls:19.42%
cases:21.46%
controls:16.00%
cases:7.19%
controls:3.15%
cases:4.20%
controls:0.16%
cases:9.52%
controls:3.22%
cases:21.73%
controls:15.76%
cases:31.72%
controls:28.38%
191
1737
710
7207
194
1435
710
7535
65
283
839
8687
38
14
866
8956
86
289
817
8677
193
1390
695
7431
263
2338
566
5900
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.1e-01
3.6e-01
8.6e-01
3.3e+00
1.2e+00
4.0e-01
1.6e-01
cases:21.20%
controls:19.42%
cases:21.46%
controls:16.02%
cases:7.19%
controls:3.17%
cases:4.20%
controls:0.16%
cases:9.52%
controls:3.22%
cases:21.85%
controls:15.78%
cases:31.72%
controls:28.43%
191
1737
710
7207
194
1437
710
7533
65
284
839
8686
38
14
866
8956
86
289
817
8677
194
1392
694
7429
263
2342
566
5896
Platelets [#/volume] in Blood
26515-7 [3007461]
1.1e-01
3.5e-01
8.7e-01
3.3e+00
1.2e+00
3.9e-01
1.6e-01
cases:21.09%
controls:19.33%
cases:21.24%
controls:15.93%
cases:7.19%
controls:3.14%
cases:4.20%
controls:0.16%
cases:9.52%
controls:3.21%
cases:21.62%
controls:15.71%
cases:31.72%
controls:28.33%
190
1729
711
7215
192
1429
712
7541
65
282
839
8688
38
14
866
8956
86
288
817
8678
192
1386
696
7435
263
2334
566
5904
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.1e-01
3.6e-01
8.7e-01
3.3e+00
1.2e+00
3.9e-01
1.6e-01
cases:21.20%
controls:19.49%
cases:21.46%
controls:16.06%
cases:7.19%
controls:3.15%
cases:4.20%
controls:0.16%
cases:9.52%
controls:3.22%
cases:21.73%
controls:15.79%
cases:31.72%
controls:28.43%
191
1743
710
7201
194
1441
710
7529
65
283
839
8687
38
14
866
8956
86
289
817
8677
193
1393
695
7428
263
2342
566
5896
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
2.1e-01
6.4e-01
7.8e-01
2.5e+00
1.7e+00
7.5e-01
5.1e-01
cases:9.66%
controls:8.01%
cases:7.19%
controls:3.94%
cases:1.33%
controls:0.61%
cases:0.66%
controls:0.06%
cases:2.77%
controls:0.54%
cases:7.88%
controls:3.88%
cases:16.28%
controls:10.49%
87
716
814
8228
65
353
839
8617
12
55
892
8915
6
5
898
8965
25
48
878
8918
70
342
818
8479
135
864
694
7374
clonazepam; oral, parenteral
N03AE01 [21604415]
1.1e+00
1.4e+00
—
—
—
1.7e+00
1.8e+00
cases:1.55%
controls:0.51%
cases:1.11%
controls:0.27%
—
—
—
—
—
—
cases:1.35%
controls:0.26%
cases:3.02%
controls:0.50%
14
46
887
8898
10
24
894
8946
—
—
—
12
23
876
8798
25
41
804
8197
Occupational therapy
R4120 [2001310234]
1.5e+00
2.5e+00
—
—
—
2.0e+00
6.7e-01
cases:1.33%
controls:0.30%
cases:1.44%
controls:0.12%
—
—
—
—
—
—
cases:1.13%
controls:0.15%
cases:0.97%
controls:0.50%
12
27
889
8917
13
11
891
8959
—
—
—
10
13
878
8808
8
41
821
8197
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
4.0e-01
8.9e-01
1.8e+00
—
1.9e+00
8.6e-01
5.4e-01
cases:8.55%
controls:5.91%
cases:7.08%
controls:3.02%
cases:2.21%
controls:0.38%
—
—
cases:2.21%
controls:0.33%
cases:6.31%
controls:2.77%
cases:13.51%
controls:8.33%
77
529
824
8415
64
271
840
8699
20
34
884
8936
—
20
30
883
8936
56
244
832
8577
112
686
717
7552
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
1.5e+00
3.5e+00
—
—
1.0e+50
—
2.4e+00
cases:0.89%
controls:0.19%
cases:1.88%
controls:0.06%
—
—
—
—
cases:1.44%
controls:0.00%
—
—
cases:1.69%
controls:0.16%
8
17
893
8927
17
5
887
8965
—
—
13
0
890
8966
—
14
13
815
8225
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
1.5e+00
3.5e+00
—
—
1.0e+50
—
2.4e+00
cases:0.89%
controls:0.19%
cases:1.88%
controls:0.06%
—
—
—
—
cases:1.44%
controls:0.00%
—
—
cases:1.69%
controls:0.16%
8
17
893
8927
17
5
887
8965
—
—
13
0
890
8966
—
14
13
815
8225
Supine thorax X-ray examination
GD1QA [2001303648]
1.3e+00
1.9e+00
—
—
—
1.3e+00
1.5e+00
cases:2.11%
controls:0.60%
cases:1.33%
controls:0.20%
—
—
—
—
—
—
cases:1.46%
controls:0.41%
cases:4.34%
controls:1.04%
19
54
882
8890
12
18
892
8952
—
—
—
13
36
875
8785
36
86
793
8152
Emergency Room and Inpatient Visit
ERIP [262]
5.8e-01
1.3e+00
2.0e+00
—
1.9e+00
6.4e-01
6.2e-01
cases:3.11%
controls:1.77%
cases:3.54%
controls:0.98%
cases:1.11%
controls:0.14%
—
—
cases:1.11%
controls:0.17%
cases:2.59%
controls:1.38%
cases:7.24%
controls:4.03%
28
158
873
8786
32
88
872
8882
10
13
894
8957
—
10
15
893
8951
23
122
865
8699
60
332
769
7906
Outpatient Hospital
22 [8756]
4.1e-01
1.0e+00
1.6e+00
—
1.3e+00
9.3e-01
5.7e-01
cases:28.63%
controls:21.11%
cases:15.27%
controls:6.21%
cases:3.76%
controls:0.81%
—
—
cases:2.44%
controls:0.65%
cases:13.51%
controls:5.80%
cases:27.86%
controls:17.89%
258
1888
643
7056
138
557
766
8413
34
73
870
8897
—
22
58
881
8908
120
512
768
8309
231
1474
598
6764
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
5.2e-01
7.6e-01
2.4e+00
1.0e+50
2.1e+00
6.1e-01
5.4e-01
cases:4.77%
controls:2.90%
cases:2.99%
controls:1.42%
cases:1.22%
controls:0.11%
cases:1.77%
controls:0.00%
cases:1.33%
controls:0.17%
cases:2.36%
controls:1.30%
cases:7.48%
controls:4.48%
43
259
858
8685
27
127
877
8843
11
10
893
8960
16
0
888
8970
12
15
891
8951
21
115
867
8706
62
369
767
7869
pregabalin; oral
N02BF02 [955152]
7.4e-01
1.3e+00
1.1e+00
—
1.2e+00
1.3e+00
1.2e+00
cases:3.88%
controls:1.90%
cases:3.21%
controls:0.88%
cases:1.11%
controls:0.36%
—
—
cases:1.33%
controls:0.39%
cases:3.72%
controls:1.04%
cases:6.51%
controls:2.12%
35
170
866
8774
29
79
875
8891
10
32
894
8938
—
12
35
891
8931
33
92
855
8729
54
175
775
8063
Essential (primary) hypertension
I10 [45591453]
2.4e-01
4.8e-01
1.4e+00
3.2e+00
1.0e+00
3.1e-01
1.7e-01
cases:8.66%
controls:6.93%
cases:5.53%
controls:3.50%
cases:2.10%
controls:0.51%
cases:1.66%
controls:0.07%
cases:1.55%
controls:0.56%
cases:5.29%
controls:3.95%
cases:11.10%
controls:9.52%
78
620
823
8324
50
314
854
8656
19
46
885
8924
15
6
889
8964
14
50
889
8916
47
348
841
8473
92
784
737
7454
Emergency Medicine
93 [38004510]
2.4e-01
8.4e-01
1.7e+00
—
1.9e+00
6.7e-01
4.9e-01
cases:8.44%
controls:6.78%
cases:7.96%
controls:3.61%
cases:2.99%
controls:0.55%
—
—
cases:2.10%
controls:0.33%
cases:6.98%
controls:3.70%
cases:17.49%
controls:11.53%
76
606
825
8338
72
324
832
8646
27
49
877
8921
—
19
30
884
8936
62
326
826
8495
145
950
684
7288
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
9.5e-01
1.9e+00
—
—
2.0e+00
1.6e+00
7.1e-01
cases:0.89%
controls:0.35%
cases:1.22%
controls:0.18%
—
—
—
—
cases:0.66%
controls:0.09%
cases:1.01%
controls:0.22%
cases:1.33%
controls:0.66%
8
31
893
8913
11
16
893
8954
—
—
6
8
897
8958
9
19
879
8802
11
54
818
8184
Urology
34 [38004474]
6.0e-01
7.8e-01
1.8e+00
—
1.4e+00
1.1e+00
1.1e+00
cases:4.88%
controls:2.73%
cases:3.10%
controls:1.44%
cases:1.33%
controls:0.21%
—
—
cases:0.89%
controls:0.21%
cases:3.83%
controls:1.36%
cases:7.72%
controls:2.78%
44
244
857
8700
28
129
876
8841
12
19
892
8951
—
8
19
895
8947
34
120
854
8701
64
229
765
8009
tizanidine; oral
M03BX02 [21604116]
3.1e-01
1.1e+00
1.4e+00
—
1.8e+00
7.1e-01
4.8e-01
cases:13.76%
controls:10.50%
cases:7.74%
controls:2.82%
cases:1.33%
controls:0.35%
—
—
cases:1.66%
controls:0.29%
cases:6.64%
controls:3.37%
cases:15.92%
controls:10.52%
124
939
777
8005
70
253
834
8717
12
31
892
8939
—
15
26
888
8940
59
297
829
8524
132
867
697
7371
pH of Serum or Plasma
2753-2 [3018418]
5.3e-01
9.7e-01
1.8e+00
—
1.8e+00
6.6e-01
7.4e-01
cases:4.33%
controls:2.58%
cases:3.98%
controls:1.55%
cases:1.00%
controls:0.17%
—
—
cases:1.11%
controls:0.19%
cases:2.93%
controls:1.54%
cases:7.60%
controls:3.79%
39
231
862
8713
36
139
868
8831
9
15
895
8955
—
10
17
893
8949
26
136
862
8685
63
312
766
7926
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2.8e-01
8.0e-01
1.6e+00
—
1.9e+00
6.0e-01
3.7e-01
cases:9.10%
controls:7.01%
cases:7.19%
controls:3.36%
cases:1.77%
controls:0.36%
—
—
cases:2.44%
controls:0.39%
cases:6.08%
controls:3.45%
cases:14.23%
controls:10.27%
82
627
819
8317
65
301
839
8669
16
32
888
8938
—
22
35
881
8931
54
304
834
8517
118
846
711
7392
montelukast; oral
R03DC03 [21603356]
7.3e-01
1.0e+00
1.5e+00
—
6.1e-01
1.1e+00
9.1e-01
cases:4.11%
controls:2.02%
cases:3.32%
controls:1.19%
cases:1.11%
controls:0.26%
—
—
cases:0.55%
controls:0.30%
cases:3.83%
controls:1.34%
cases:5.55%
controls:2.32%
37
181
864
8763
30
107
874
8863
10
23
894
8947
—
5
27
898
8939
34
118
854
8703
46
191
783
8047
Limited function/disability (L)
L28 [2002000647]
1.0e+00
1.9e+00
2.0e+00
—
—
1.3e+00
9.2e-01
cases:2.22%
controls:0.83%
cases:1.99%
controls:0.29%
cases:0.55%
controls:0.08%
—
—
—
—
cases:1.91%
controls:0.52%
cases:3.74%
controls:1.52%
20
74
881
8870
18
26
886
8944
5
7
899
8963
—
—
17
46
871
8775
31
125
798
8113
Bacteria [Presence] in Urine
87829-8 [36304419]
3.1e-01
1.1e+00
—
—
2.1e+00
1.0e+00
8.8e-01
cases:3.44%
controls:2.54%
cases:3.76%
controls:1.30%
—
—
—
—
cases:1.22%
controls:0.14%
cases:3.49%
controls:1.29%
cases:8.08%
controls:3.53%
31
227
870
8717
34
117
870
8853
—
—
11
13
892
8953
31
114
857
8707
67
291
762
7947
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
2.2e-01
4.4e-01
8.3e-01
2.1e+00
1.2e+00
5.1e-01
2.4e-01
cases:18.76%
controls:15.62%
cases:17.15%
controls:11.76%
cases:4.31%
controls:1.93%
cases:0.66%
controls:0.08%
cases:6.42%
controls:2.06%
cases:17.91%
controls:11.55%
cases:28.35%
controls:23.67%
169
1397
732
7547
155
1055
749
7915
39
173
865
8797
6
7
898
8963
58
185
845
8781
159
1019
729
7802
235
1950
594
6288
Concussion
S06.0 [45582805]
7.0e-01
2.1e+00
1.0e+50
—
—
2.0e+00
9.6e-01
cases:1.89%
controls:0.95%
cases:1.55%
controls:0.20%
cases:0.77%
controls:0.00%
—
—
—
—
cases:1.35%
controls:0.18%
cases:2.77%
controls:1.08%
17
85
884
8859
14
18
890
8952
7
0
897
8970
—
—
12
16
876
8805
23
89
806
8149
Spinal stenosis
M48.0 [45557888]
1.0e+00
1.5e+00
2.1e+00
—
—
1.3e+00
1.2e+00
cases:2.00%
controls:0.74%
cases:1.55%
controls:0.35%
cases:0.55%
controls:0.07%
—
—
—
—
cases:1.46%
controls:0.40%
cases:3.02%
controls:0.95%
18
66
883
8878
14
31
890
8939
5
6
899
8964
—
—
13
35
875
8786
25
78
804
8160
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
6.4e-01
8.4e-01
5.3e-01
—
1.7e+00
1.1e+00
7.6e-01
cases:6.99%
controls:3.80%
cases:5.09%
controls:2.25%
cases:0.66%
controls:0.39%
—
—
cases:2.33%
controls:0.45%
cases:5.74%
controls:2.04%
cases:10.86%
controls:5.38%
63
340
838
8604
46
202
858
8768
6
35
898
8935
—
21
40
882
8926
51
180
837
8641
90
443
739
7795
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
3.9e-01
9.8e-01
9.6e-01
—
2.2e+00
9.6e-01
7.7e-01
cases:4.99%
controls:3.42%
cases:4.76%
controls:1.84%
cases:0.66%
controls:0.26%
—
—
cases:1.66%
controls:0.19%
cases:4.62%
controls:1.81%
cases:9.77%
controls:4.79%
45
306
856
8638
43
165
861
8805
6
23
898
8947
—
15
17
888
8949
41
160
847
8661
81
395
748
7843
Physiotherapist
Z3226 [2001311560]
7.0e-01
1.6e+00
—
—
—
1.3e+00
1.3e+00
cases:3.77%
controls:1.91%
cases:2.10%
controls:0.43%
—
—
—
—
—
—
cases:1.58%
controls:0.44%
cases:3.98%
controls:1.13%
34
171
867
8773
19
39
885
8931
—
—
—
14
39
874
8782
33
93
796
8145
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
2.8e-01
1.0e+00
—
—
2.0e+00
9.6e-01
8.7e-01
cases:3.44%
controls:2.62%
cases:3.76%
controls:1.38%
—
—
—
—
cases:1.22%
controls:0.17%
cases:3.72%
controls:1.46%
cases:8.32%
controls:3.65%
31
234
870
8710
34
124
870
8846
—
—
11
15
892
8951
33
129
855
8692
69
301
760
7937
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
1.4e+00
1.7e+00
—
—
—
1.8e+00
—
cases:1.22%
controls:0.31%
cases:1.22%
controls:0.22%
—
—
—
—
—
—
cases:0.79%
controls:0.14%
—
—
11
28
890
8916
11
20
893
8950
—
—
—
7
12
881
8809
—
Home Visit
OMOP4822459 [581476]
5.1e-01
1.0e+00
1.3e+00
—
1.1e+00
8.4e-01
5.3e-01
cases:4.66%
controls:2.84%
cases:3.65%
controls:1.35%
cases:1.44%
controls:0.40%
—
—
cases:1.55%
controls:0.50%
cases:3.83%
controls:1.69%
cases:7.72%
controls:4.71%
42
254
859
8690
33
121
871
8849
13
36
891
8934
—
14
45
889
8921
34
149
854
8672
64
388
765
7850
Case Management Agency
251B00000X [38004193]
1.1e-01
2.7e-01
5.9e-01
3.3e+00
6.0e-01
2.4e-01
1.5e-01
cases:40.95%
controls:38.39%
cases:38.72%
controls:32.58%
cases:20.91%
controls:12.76%
cases:16.92%
controls:0.76%
cases:21.59%
controls:13.11%
cases:40.32%
controls:34.76%
cases:53.56%
controls:49.77%
369
3434
532
5510
350
2922
554
6048
189
1145
715
7825
153
68
751
8902
195
1175
708
7791
358
3066
530
5755
444
4100
385
4138
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
5.8e-01
9.3e-01
9.1e-01
—
1.7e+00
7.6e-01
7.0e-01
cases:6.88%
controls:3.97%
cases:6.31%
controls:2.58%
cases:0.88%
controls:0.36%
—
—
cases:1.55%
controls:0.29%
cases:4.84%
controls:2.34%
cases:10.86%
controls:5.72%
62
355
839
8589
57
231
847
8739
8
32
896
8938
—
14
26
889
8940
43
206
845
8615
90
471
739
7767
ranitidine bismuth citrate; oral
A02BA07 [21600088]
1.1e+00
1.3e+00
—
—
—
1.1e+00
1.2e+00
cases:3.88%
controls:1.39%
cases:1.44%
controls:0.41%
—
—
—
—
—
—
cases:1.58%
controls:0.53%
cases:3.50%
controls:1.04%
35
124
866
8820
13
37
891
8933
—
—
—
14
47
874
8774
29
86
800
8152
ranitidine; oral, parenteral
A02BA02 [21600083]
1.1e+00
1.3e+00
—
—
—
1.1e+00
1.2e+00
cases:3.88%
controls:1.39%
cases:1.44%
controls:0.41%
—
—
—
—
—
—
cases:1.58%
controls:0.53%
cases:3.50%
controls:1.04%
35
124
866
8820
13
37
891
8933
—
—
—
14
47
874
8774
29
86
800
8152
oxcarbazepine; oral
N03AF02 [21604418]
1.5e+00
1.5e+00
—
—
—
1.6e+00
1.1e+00
cases:1.89%
controls:0.44%
cases:1.55%
controls:0.35%
—
—
—
—
—
—
cases:1.46%
controls:0.29%
cases:1.45%
controls:0.50%
17
39
884
8905
14
31
890
8939
—
—
—
13
26
875
8795
12
41
817
8197
venlafaxine; oral
N06AX16 [21604745]
9.5e-01
1.2e+00
1.2e+00
—
1.3e+00
1.2e+00
6.4e-01
cases:2.77%
controls:1.10%
cases:2.10%
controls:0.65%
cases:0.55%
controls:0.17%
—
—
cases:1.22%
controls:0.33%
cases:2.70%
controls:0.86%
cases:3.26%
controls:1.75%
25
98
876
8846
19
58
885
8912
5
15
899
8955
—
11
30
892
8936
24
76
864
8745
27
144
802
8094
pantoprazole; oral, parenteral
A02BC02 [21600097]
5.4e-01
6.1e-01
9.1e-01
—
1.2e+00
7.4e-01
5.8e-01
cases:14.43%
controls:8.92%
cases:8.41%
controls:4.74%
cases:2.21%
controls:0.90%
—
—
cases:2.88%
controls:0.89%
cases:10.02%
controls:5.07%
cases:18.21%
controls:11.08%
130
798
771
8146
76
425
828
8545
20
81
884
8889
—
26
80
877
8886
89
447
799
8374
151
913
678
7325
Migraine without aura [common migraine]
G43.0 [45600784]
6.5e-01
1.6e+00
—
—
—
2.0e+00
1.0e+00
cases:1.00%
controls:0.53%
cases:1.00%
controls:0.20%
—
—
—
—
—
—
cases:1.35%
controls:0.19%
cases:2.65%
controls:1.00%
9
47
892
8897
9
18
895
8952
—
—
—
12
17
876
8804
22
82
807
8156
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
2.9e-01
9.1e-01
1.2e+00
—
2.1e+00
8.4e-01
7.2e-01
cases:3.88%
controls:2.93%
cases:3.98%
controls:1.65%
cases:0.77%
controls:0.23%
—
—
cases:1.44%
controls:0.18%
cases:3.83%
controls:1.69%
cases:8.44%
controls:4.31%
35
262
866
8682
36
148
868
8822
7
21
897
8949
—
13
16
890
8950
34
149
854
8672
70
355
759
7883
Mixed anxiety and depressive disorder
F41.2 [45566845]
1.0e+00
5.9e-01
—
—
2.1e+00
1.4e+00
6.6e-01
cases:1.66%
controls:0.61%
cases:0.66%
controls:0.37%
—
—
—
—
cases:0.66%
controls:0.08%
cases:1.46%
controls:0.36%
cases:2.29%
controls:1.20%
15
55
886
8889
6
33
898
8937
—
—
6
7
897
8959
13
32
875
8789
19
99
810
8139
Leukocytes [#/volume] in Urine
30405-5 [3018095]
2.3e-01
7.9e-01
9.9e-01
—
2.3e+00
8.2e-01
6.6e-01
cases:4.22%
controls:3.37%
cases:4.31%
controls:2.00%
cases:0.77%
controls:0.29%
—
—
cases:1.77%
controls:0.19%
cases:4.62%
controls:2.10%
cases:9.89%
controls:5.39%
38
301
863
8643
39
179
865
8791
7
26
897
8944
—
16
17
887
8949
41
185
847
8636
82
444
747
7794
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
R5110 [2001310246]
9.2e-01
1.9e+00
—
1.0e+50
—
1.6e+00
1.0e+00
cases:1.55%
controls:0.63%
cases:1.33%
controls:0.20%
—
—
cases:0.66%
controls:0.00%
—
—
cases:1.58%
controls:0.33%
cases:2.77%
controls:1.03%
14
56
887
8888
12
18
892
8952
—
6
0
898
8970
—
14
29
874
8792
23
85
806
8153
clopidogrel; oral
B01AC04 [21600989]
1.8e-01
5.8e-01
1.1e+00
—
2.1e+00
1.4e+00
9.5e-01
cases:1.44%
controls:1.21%
cases:1.44%
controls:0.81%
cases:0.77%
controls:0.27%
—
—
cases:1.33%
controls:0.17%
cases:3.04%
controls:0.74%
cases:3.86%
controls:1.53%
13
108
888
8836
13
73
891
8897
7
24
897
8946
—
12
15
891
8951
27
65
861
8756
32
126
797
8112
Fitting and adjustment of other specified devices
Z46.8 [45581035]
2.0e+00
—
—
—
—
—
2.5e+00
cases:0.67%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.07%
6
8
895
8936
—
—
—
—
—
7
6
822
8232
Basophils [#/volume] in Blood
26444-0 [3006315]
4.2e-01
5.2e-01
9.7e-01
—
1.5e+00
7.7e-01
7.2e-01
cases:8.66%
controls:5.86%
cases:6.31%
controls:3.86%
cases:1.88%
controls:0.72%
—
—
cases:2.21%
controls:0.51%
cases:6.98%
controls:3.36%
cases:14.72%
controls:7.76%
78
524
823
8420
57
346
847
8624
17
65
887
8905
—
20
46
883
8920
62
296
826
8525
122
639
707
7599
Monocytes [#/volume] in Blood
26484-6 [3001604]
4.2e-01
5.2e-01
9.5e-01
—
1.5e+00
7.7e-01
7.2e-01
cases:8.66%
controls:5.88%
cases:6.31%
controls:3.86%
cases:1.88%
controls:0.74%
—
—
cases:2.21%
controls:0.51%
cases:6.98%
controls:3.37%
cases:14.72%
controls:7.77%
78
526
823
8418
57
346
847
8624
17
66
887
8904
—
20
46
883
8920
62
297
826
8524
122
640
707
7598
Laboratory Visit
OMOP4822461 [32036]
8.0e-02
1.7e-01
7.2e-01
2.9e+00
8.1e-01
2.6e-01
7.1e-02
cases:23.64%
controls:22.23%
cases:23.89%
controls:20.93%
cases:11.62%
controls:6.00%
cases:5.09%
controls:0.30%
cases:13.18%
controls:6.31%
cases:25.90%
controls:21.22%
cases:34.02%
controls:32.45%
213
1988
688
6956
216
1877
688
7093
105
538
799
8432
46
27
858
8943
119
566
784
8400
230
1872
658
6949
282
2673
547
5565
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
4.2e-01
5.4e-01
1.0e+00
—
1.4e+00
7.6e-01
6.9e-01
cases:8.21%
controls:5.55%
cases:5.75%
controls:3.44%
cases:1.77%
controls:0.65%
—
—
cases:1.88%
controls:0.47%
cases:6.42%
controls:3.09%
cases:13.15%
controls:7.09%
74
496
827
8448
52
309
852
8661
16
58
888
8912
—
17
42
886
8924
57
273
831
8548
109
584
720
7654
Monocytes/Leukocytes in Blood
26485-3 [3019069]
4.1e-01
5.2e-01
9.8e-01
—
1.4e+00
7.8e-01
6.9e-01
cases:8.21%
controls:5.60%
cases:5.75%
controls:3.49%
cases:1.77%
controls:0.67%
—
—
cases:1.88%
controls:0.47%
cases:6.53%
controls:3.09%
cases:13.15%
controls:7.06%
74
501
827
8443
52
313
852
8657
16
60
888
8910
—
17
42
886
8924
58
273
830
8548
109
582
720
7656
Basophils/Leukocytes in Blood
30180-4 [3022096]
4.2e-01
5.3e-01
1.0e+00
—
1.4e+00
7.6e-01
6.8e-01
cases:8.21%
controls:5.57%
cases:5.75%
controls:3.47%
cases:1.77%
controls:0.66%
—
—
cases:1.88%
controls:0.47%
cases:6.42%
controls:3.09%
cases:13.15%
controls:7.10%
74
498
827
8446
52
311
852
8659
16
59
888
8911
—
17
42
886
8924
57
273
831
8548
109
585
720
7653
Rheumatism, unspecified
M79.0 [45567658]
1.7e+00
—
—
—
—
2.6e+00
—
cases:1.44%
controls:0.26%
—
—
—
—
—
—
—
—
cases:0.79%
controls:0.06%
—
—
13
23
888
8921
—
—
—
—
7
5
881
8816
—
Complex partial epileptic seizure with secondary generalization
G40.22 [2000502141]
1.3e+00
1.8e+00
—
—
—
2.6e+00
1.8e+00
cases:0.67%
controls:0.19%
cases:0.66%
controls:0.11%
—
—
—
—
—
—
cases:0.90%
controls:0.07%
cases:1.21%
controls:0.21%
6
17
895
8927
6
10
898
8960
—
—
—
8
6
880
8815
10
17
819
8221
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
3.9e-01
5.3e-01
9.5e-01
—
1.4e+00
7.4e-01
7.0e-01
cases:8.88%
controls:6.19%
cases:6.53%
controls:3.96%
cases:1.88%
controls:0.74%
—
—
cases:2.21%
controls:0.54%
cases:6.98%
controls:3.45%
cases:14.84%
controls:7.98%
80
554
821
8390
59
355
845
8615
17
66
887
8904
—
20
48
883
8918
62
304
826
8517
123
657
706
7581
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
4.0e-01
5.4e-01
1.0e+00
—
1.4e+00
7.6e-01
6.6e-01
cases:8.44%
controls:5.83%
cases:5.97%
controls:3.56%
cases:1.77%
controls:0.66%
—
—
cases:1.88%
controls:0.48%
cases:6.53%
controls:3.16%
cases:13.27%
controls:7.33%
76
521
825
8423
54
319
850
8651
16
59
888
8911
—
17
43
886
8923
58
279
830
8542
110
604
719
7634
Eosinophils [#/volume] in Blood
26449-9 [3013115]
3.7e-01
4.9e-01
9.7e-01
—
1.4e+00
7.8e-01
6.9e-01
cases:8.66%
controls:6.14%
cases:6.42%
controls:4.02%
cases:1.88%
controls:0.72%
—
—
cases:2.33%
controls:0.57%
cases:7.21%
controls:3.45%
cases:15.08%
controls:8.21%
78
549
823
8395
58
361
846
8609
17
65
887
8905
—
21
51
882
8915
64
304
824
8517
125
676
704
7562
Abdominal X-ray examination without contrast
JN3AA [2001305553]
8.2e-01
2.5e+00
—
—
—
—
1.9e+00
cases:0.55%
controls:0.25%
cases:0.77%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.57%
controls:0.24%
5
22
896
8922
7
6
897
8964
—
—
—
—
13
20
816
8218
Audiology
64 [38004489]
7.5e-01
9.9e-01
—
—
—
1.5e+00
1.1e+00
cases:3.11%
controls:1.50%
cases:1.66%
controls:0.62%
—
—
—
—
—
—
cases:2.70%
controls:0.63%
cases:4.83%
controls:1.63%
28
134
873
8810
15
56
889
8914
—
—
—
24
56
864
8765
40
134
789
8104
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
8.0e-01
9.8e-01
1.8e+00
—
1.5e+00
4.6e-01
7.7e-01
cases:3.00%
controls:1.36%
cases:1.77%
controls:0.67%
cases:0.77%
controls:0.13%
—
—
cases:0.55%
controls:0.12%
cases:1.35%
controls:0.86%
cases:5.43%
controls:2.59%
27
122
874
8822
16
60
888
8910
7
12
897
8958
—
5
11
898
8955
12
76
876
8745
45
213
784
8025
Otolaryngology
4 [38004449]
5.3e-01
8.5e-01
1.0e+00
—
1.2e+00
9.1e-01
8.0e-01
cases:13.98%
controls:8.72%
cases:7.08%
controls:3.14%
cases:1.22%
controls:0.43%
—
—
cases:1.66%
controls:0.50%
cases:6.87%
controls:2.89%
cases:17.61%
controls:8.79%
126
780
775
8164
64
282
840
8688
11
39
893
8931
—
15
45
888
8921
61
255
827
8566
146
724
683
7514
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
3.9e-01
5.6e-01
1.0e+00
—
1.4e+00
7.3e-01
6.0e-01
cases:8.10%
controls:5.66%
cases:5.97%
controls:3.49%
cases:1.77%
controls:0.65%
—
—
cases:1.88%
controls:0.48%
cases:6.31%
controls:3.14%
cases:12.42%
controls:7.22%
73
506
828
8438
54
313
850
8657
16
58
888
8912
—
17
43
886
8923
56
277
832
8544
103
595
726
7643
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
5.0e-01
8.9e-01
8.9e-01
—
1.5e+00
7.1e-01
6.6e-01
cases:7.21%
controls:4.51%
cases:5.64%
controls:2.41%
cases:1.22%
controls:0.50%
—
—
cases:1.99%
controls:0.43%
cases:5.07%
controls:2.56%
cases:11.58%
controls:6.32%
65
403
836
8541
51
216
853
8754
11
45
893
8925
—
18
39
885
8927
45
226
843
8595
96
521
733
7717
amitriptyline; oral, parenteral
N06AA09 [21604696]
9.1e-01
1.3e+00
1.0e+00
—
—
1.1e+00
9.7e-01
cases:5.33%
controls:2.22%
cases:3.54%
controls:1.01%
cases:0.66%
controls:0.25%
—
—
—
—
cases:3.15%
controls:1.07%
cases:6.76%
controls:2.68%
48
199
853
8745
32
91
872
8879
6
22
898
8948
—
—
28
94
860
8727
56
221
773
8017
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
5.7e-01
9.1e-01
1.1e+00
—
1.5e+00
6.3e-01
6.6e-01
cases:7.44%
controls:4.36%
cases:6.64%
controls:2.79%
cases:1.33%
controls:0.43%
—
—
cases:1.55%
controls:0.36%
cases:4.84%
controls:2.63%
cases:11.82%
controls:6.46%
67
390
834
8554
60
250
844
8720
12
39
892
8931
—
14
32
889
8934
43
232
845
8589
98
532
731
7706
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
3.2e-01
6.4e-01
1.2e+00
—
1.7e+00
5.7e-01
3.1e-01
cases:11.99%
controls:9.01%
cases:8.63%
controls:4.76%
cases:2.10%
controls:0.61%
—
—
cases:3.65%
controls:0.66%
cases:7.55%
controls:4.42%
cases:16.04%
controls:12.27%
108
806
793
8138
78
427
826
8543
19
55
885
8915
—
33
59
870
8907
67
390
821
8431
133
1011
696
7227
Limited function/disability NOS
A28 [2002000162]
8.7e-01
1.5e+00
1.8e+00
—
1.7e+00
9.2e-01
8.2e-01
cases:2.00%
controls:0.85%
cases:1.88%
controls:0.41%
cases:0.88%
controls:0.14%
—
—
cases:0.78%
controls:0.14%
cases:1.24%
controls:0.50%
cases:3.14%
controls:1.41%
18
76
883
8868
17
37
887
8933
8
13
896
8957
—
7
13
896
8953
11
44
877
8777
26
116
803
8122
Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]
2.3e+00
—
—
1.0e+50
—
—
1.8e+00
cases:1.11%
controls:0.11%
—
—
—
—
cases:0.77%
controls:0.00%
—
—
—
—
cases:1.33%
controls:0.22%
10
10
891
8934
—
—
7
0
897
8970
—
—
11
18
818
8220
methenamine; oral
J01XX05 [21603065]
—
2.1e+00
—
—
—
—
1.9e+00
—
—
cases:0.66%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.12%
—
6
7
898
8963
—
—
—
—
7
10
822
8228
Dry eye syndrome
H04.10 [2000502254]
1.2e+00
1.9e+00
—
1.0e+50
—
1.0e+00
1.1e+00
cases:1.89%
controls:0.59%
cases:1.00%
controls:0.16%
—
—
cases:0.66%
controls:0.00%
—
—
cases:0.68%
controls:0.24%
cases:2.77%
controls:0.98%
17
53
884
8891
9
14
895
8956
—
6
0
898
8970
—
6
21
882
8800
23
81
806
8157
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
6.3e-01
1.1e+00
—
—
2.3e+00
7.6e-01
6.4e-01
cases:2.11%
controls:1.13%
cases:1.99%
controls:0.69%
—
—
—
—
cases:0.78%
controls:0.08%
cases:1.80%
controls:0.85%
cases:4.70%
controls:2.52%
19
101
882
8843
18
62
886
8908
—
—
7
7
896
8959
16
75
872
8746
39
208
790
8030
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
8.5e-01
1.1e+00
1.0e+00
—
—
1.1e+00
9.3e-01
cases:4.33%
controls:1.90%
cases:2.77%
controls:0.90%
cases:0.66%
controls:0.25%
—
—
—
—
cases:2.14%
controls:0.74%
cases:4.34%
controls:1.76%
39
170
862
8774
25
81
879
8889
6
22
898
8948
—
—
19
65
869
8756
36
145
793
8093
More than one and less than three hours
ZXE10 [2001311401]
4.0e-01
9.6e-01
1.9e+00
—
—
1.1e+00
5.6e-01
cases:5.55%
controls:3.80%
cases:2.65%
controls:1.04%
cases:0.77%
controls:0.11%
—
—
—
—
cases:2.59%
controls:0.90%
cases:4.58%
controls:2.66%
50
340
851
8604
24
93
880
8877
7
10
897
8960
—
—
23
79
865
8742
38
219
791
8019
Differential panel, method unspecified - Blood
69738-3 [42870588]
5.5e-01
5.3e-01
1.2e+00
—
1.6e+00
9.4e-01
9.1e-01
cases:6.33%
controls:3.73%
cases:3.98%
controls:2.39%
cases:1.33%
controls:0.41%
—
—
cases:1.55%
controls:0.32%
cases:5.52%
controls:2.23%
cases:11.10%
controls:4.81%
57
334
844
8610
36
214
868
8756
12
37
892
8933
—
14
29
889
8937
49
197
839
8624
92
396
737
7842
androstanolone
G03BB02 [21602513]
9.6e-01
2.0e+00
—
—
-1.0e+50
2.0e+00
1.5e+00
cases:0.55%
controls:0.21%
cases:0.88%
controls:0.12%
—
—
—
—
cases:0.00%
controls:0.08%
cases:0.90%
controls:0.12%
cases:0.84%
controls:0.19%
5
19
896
8925
8
11
896
8959
—
—
0
7
903
8959
8
11
880
8810
7
16
822
8222
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
6.3e-01
1.0e+00
—
—
2.3e+00
6.8e-01
6.4e-01
cases:2.22%
controls:1.20%
cases:1.77%
controls:0.65%
—
—
—
—
cases:0.89%
controls:0.09%
cases:1.58%
controls:0.80%
cases:4.22%
controls:2.28%
20
107
881
8837
16
58
888
8912
—
—
8
8
895
8958
14
71
874
8750
35
188
794
8050
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
1.3e+00
1.5e+00
—
—
—
1.3e+00
1.2e+00
cases:1.44%
controls:0.41%
cases:1.33%
controls:0.29%
—
—
—
—
—
—
cases:1.01%
controls:0.28%
cases:1.69%
controls:0.53%
13
37
888
8907
12
26
892
8944
—
—
—
9
25
879
8796
14
44
815
8194
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
1.9e+00
2.0e+00
—
—
—
—
—
cases:1.22%
controls:0.18%
cases:0.66%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
11
16
890
8928
6
8
898
8962
—
—
—
—
—
Supplier / Service Provider
OMOP5117446 [33004]
-1.1e+00
-7.9e-01
—
—
—
2.6e+00
3.2e+00
cases:9.10%
controls:23.37%
cases:4.20%
controls:8.82%
—
—
—
—
—
—
cases:4.39%
controls:0.33%
cases:12.18%
controls:0.58%
82
2090
819
6854
38
791
866
8179
—
—
—
39
29
849
8792
101
48
728
8190
androstanolone
A14AA01 [21600917]
9.6e-01
2.0e+00
—
—
-1.0e+50
1.9e+00
1.5e+00
cases:0.55%
controls:0.21%
cases:0.88%
controls:0.12%
—
—
—
—
cases:0.00%
controls:0.08%
cases:0.90%
controls:0.14%
cases:0.97%
controls:0.22%
5
19
896
8925
8
11
896
8959
—
—
0
7
903
8959
8
12
880
8809
8
18
821
8220
Asthma, unspecified
J45.9 [45562456]
8.8e-01
1.0e+00
—
1.0e+50
—
1.1e+00
8.4e-01
cases:4.11%
controls:1.74%
cases:2.32%
controls:0.86%
—
—
cases:0.55%
controls:0.00%
—
—
cases:3.04%
controls:1.03%
cases:5.31%
controls:2.37%
37
156
864
8788
21
77
883
8893
—
5
0
899
8970
—
27
91
861
8730
44
195
785
8043
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
9.1e-01
1.9e+00
—
—
—
1.9e+00
9.6e-01
cases:1.00%
controls:0.40%
cases:1.22%
controls:0.18%
—
—
—
—
—
—
cases:1.13%
controls:0.17%
cases:1.45%
controls:0.56%
9
36
892
8908
11
16
893
8954
—
—
—
10
15
878
8806
12
46
817
8192
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
1.8e+00
2.0e+00
—
—
—
—
—
cases:1.11%
controls:0.19%
cases:0.66%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
10
17
891
8927
6
8
898
8962
—
—
—
—
—
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
2.9e-01
4.9e-01
9.6e-01
—
1.1e+00
5.2e-01
4.7e-01
cases:23.09%
controls:18.31%
cases:14.38%
controls:9.34%
cases:3.98%
controls:1.56%
—
—
cases:4.43%
controls:1.58%
cases:15.09%
controls:9.58%
cases:32.57%
controls:23.27%
208
1638
693
7306
130
838
774
8132
36
140
868
8830
—
40
142
863
8824
134
845
754
7976
270
1917
559
6321
Other specified intervertebral disc degeneration
M51.3 [45591865]
4.7e-01
1.8e+00
—
—
—
1.9e+00
8.4e-01
cases:0.89%
controls:0.56%
cases:0.88%
controls:0.14%
—
—
—
—
—
—
cases:0.79%
controls:0.11%
cases:1.09%
controls:0.47%
8
50
893
8894
8
13
896
8957
—
—
—
7
10
881
8811
9
39
820
8199
chlorprothixene; oral, parenteral
N05AF03 [21604533]
1.9e+00
—
—
—
—
—
1.9e+00
cases:1.00%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.13%
9
14
892
8930
—
—
—
—
—
7
11
822
8227
Paraesthesia of skin
R20.2 [45568120]
5.1e-01
2.0e+00
—
—
—
1.7e+00
9.0e-01
cases:0.67%
controls:0.40%
cases:1.11%
controls:0.14%
—
—
—
—
—
—
cases:1.01%
controls:0.19%
cases:1.45%
controls:0.59%
6
36
895
8908
10
13
894
8957
—
—
—
9
17
879
8804
12
49
817
8189
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
1.6e+00
2.1e+00
—
—
—
—
1.1e+00
cases:1.11%
controls:0.23%
cases:0.66%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.33%
10
21
891
8923
6
7
898
8963
—
—
—
—
8
27
821
8211
oxycodone; oral, parenteral
N02AA05 [21604260]
9.0e-01
1.5e+00
1.0e+00
—
1.8e+00
1.3e+00
8.1e-01
cases:1.55%
controls:0.64%
cases:1.44%
controls:0.32%
cases:0.55%
controls:0.20%
—
—
cases:0.66%
controls:0.11%
cases:1.91%
controls:0.51%
cases:2.77%
controls:1.25%
14
57
887
8887
13
29
891
8941
5
18
899
8952
—
6
10
897
8956
17
45
871
8776
23
103
806
8135
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
8.1e-01
1.5e+00
2.1e+00
—
1.8e+00
1.1e+00
2.9e-01
cases:2.33%
controls:1.05%
cases:1.33%
controls:0.31%
cases:0.66%
controls:0.08%
—
—
cases:0.55%
controls:0.09%
cases:1.24%
controls:0.40%
cases:2.17%
controls:1.63%
21
94
880
8850
12
28
892
8942
6
7
898
8963
—
5
8
898
8958
11
35
877
8786
18
134
811
8104
Sequelae of cerebral infarction
I69.3 [45533476]
5.3e-01
1.4e+00
—
—
—
2.0e+00
1.6e+00
cases:0.67%
controls:0.39%
cases:0.77%
controls:0.19%
—
—
—
—
—
—
cases:1.58%
controls:0.23%
cases:2.41%
controls:0.49%
6
35
895
8909
7
17
897
8953
—
—
—
14
20
874
8801
20
40
809
8198
duloxetine; oral
N06AX21 [21604749]
9.5e-01
1.1e+00
—
—
—
1.3e+00
1.3e+00
cases:2.11%
controls:0.83%
cases:1.33%
controls:0.47%
—
—
—
—
—
—
cases:2.14%
controls:0.58%
cases:4.22%
controls:1.20%
19
74
882
8870
12
42
892
8928
—
—
—
19
51
869
8770
35
99
794
8139
Epilepsy, unspecified
G40.9 [45562083]
1.1e+00
1.2e+00
—
—
—
1.8e+00
1.7e+00
cases:0.89%
controls:0.30%
cases:0.66%
controls:0.20%
—
—
—
—
—
—
cases:1.13%
controls:0.18%
cases:1.81%
controls:0.33%
8
27
893
8917
6
18
898
8952
—
—
—
10
16
878
8805
15
27
814
8211
Epilepsy
G40 [45595935]
1.4e+00
1.6e+00
—
—
—
2.2e+00
1.3e+00
cases:1.11%
controls:0.28%
cases:0.55%
controls:0.11%
—
—
—
—
—
—
cases:0.79%
controls:0.09%
cases:0.84%
controls:0.23%
10
25
891
8919
5
10
899
8960
—
—
—
7
8
881
8813
7
19
822
8219
Pharmacy visit
OMOP4822462 [581458]
2.1e-01
3.2e-01
4.0e-01
9.6e-01
5.3e-01
4.4e-01
8.3e-01
cases:90.57%
controls:88.62%
cases:78.54%
controls:72.64%
cases:40.60%
controls:31.34%
cases:3.87%
controls:1.52%
cases:44.41%
controls:31.92%
cases:81.31%
controls:73.61%
cases:96.26%
controls:91.83%
816
7926
85
1018
710
6516
194
2454
367
2811
537
6159
35
136
869
8834
401
2862
502
6104
722
6493
166
2328
798
7565
31
673
Respiratory and circulatory monitoring
WX700 [2001310817]
1.1e+00
9.7e-01
—
—
—
1.4e+00
9.6e-01
cases:3.44%
controls:1.19%
cases:1.11%
controls:0.42%
—
—
—
—
—
—
cases:1.24%
controls:0.31%
cases:2.77%
controls:1.08%
31
106
870
8838
10
38
894
8932
—
—
—
11
27
877
8794
23
89
806
8149
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
2.9e-01
5.0e-01
1.1e+00
—
1.3e+00
5.2e-01
2.2e-01
cases:15.87%
controls:12.39%
cases:12.28%
controls:7.85%
cases:2.32%
controls:0.78%
—
—
cases:4.10%
controls:1.13%
cases:12.50%
controls:7.82%
cases:22.92%
controls:19.24%
143
1108
758
7836
111
704
793
8266
21
70
883
8900
—
37
101
866
8865
111
690
777
8131
190
1585
639
6653
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
2.0e+00
—
—
—
—
1.5e+00
1.4e+00
cases:1.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.12%
cases:1.21%
controls:0.29%
9
12
892
8932
—
—
—
—
5
11
883
8810
10
24
819
8214
Inpatient Visit
IP [9201]
2.7e-01
7.3e-01
1.2e+00
1.0e+50
2.6e+00
7.3e-01
8.0e-01
cases:4.77%
controls:3.70%
cases:2.54%
controls:1.25%
cases:0.55%
controls:0.17%
cases:2.10%
controls:0.00%
cases:0.78%
controls:0.06%
cases:2.36%
controls:1.16%
cases:7.84%
controls:3.67%
43
331
858
8613
23
112
881
8858
5
15
899
8955
19
0
885
8970
7
5
896
8961
21
102
867
8719
65
302
764
7936
macrogol; oral
A06AD15 [21600575]
1.1e+00
1.2e+00
—
—
—
1.4e+00
9.5e-01
cases:2.00%
controls:0.67%
cases:1.00%
controls:0.29%
—
—
—
—
—
—
cases:1.35%
controls:0.35%
cases:2.41%
controls:0.95%
18
60
883
8884
9
26
895
8944
—
—
—
12
31
876
8790
20
78
809
8160
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
1.3e+00
2.1e+00
—
—
—
1.7e+00
6.9e-01
cases:1.78%
controls:0.47%
cases:1.99%
controls:0.26%
—
—
—
—
—
—
cases:0.68%
controls:0.12%
cases:0.97%
controls:0.49%
16
42
885
8902
18
23
886
8947
—
—
—
6
11
882
8810
8
40
821
8198
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
6.5e-01
1.2e+00
1.1e+00
—
1.0e+00
8.5e-01
7.5e-01
cases:8.21%
controls:4.48%
cases:5.31%
controls:1.74%
cases:1.11%
controls:0.38%
—
—
cases:1.00%
controls:0.36%
cases:4.39%
controls:1.93%
cases:9.65%
controls:4.78%
74
401
827
8543
48
156
856
8814
10
34
894
8936
—
9
32
894
8934
39
170
849
8651
80
394
749
7844
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
5.7e-01
1.1e+00
—
—
—
1.4e+00
9.0e-01
cases:2.22%
controls:1.26%
cases:1.77%
controls:0.62%
—
—
—
—
—
—
cases:2.59%
controls:0.65%
cases:3.98%
controls:1.66%
20
113
881
8831
16
56
888
8914
—
—
—
23
57
865
8764
33
137
796
8101
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
3.1e-01
5.6e-01
1.3e+00
—
1.0e+00
5.1e-01
2.2e-01
cases:12.65%
controls:9.59%
cases:9.07%
controls:5.38%
cases:1.88%
controls:0.54%
—
—
cases:2.21%
controls:0.83%
cases:8.78%
controls:5.45%
cases:17.49%
controls:14.59%
114
858
787
8086
82
483
822
8487
17
48
887
8922
—
20
74
883
8892
78
481
810
8340
145
1202
684
7036
Psychologist
Z2445 [2001311558]
1.1e+00
8.6e-01
—
—
—
2.2e+00
1.5e+00
cases:1.55%
controls:0.50%
cases:0.55%
controls:0.23%
—
—
—
—
—
—
cases:1.01%
controls:0.11%
cases:1.09%
controls:0.25%
14
45
887
8899
5
21
899
8949
—
—
—
9
10
879
8811
9
21
820
8217
pH of Urine
2756-5 [3015736]
5.2e-01
5.6e-01
—
—
2.1e+00
7.5e-01
3.5e-01
cases:6.10%
controls:3.73%
cases:3.54%
controls:2.06%
—
—
—
—
cases:1.55%
controls:0.20%
cases:4.95%
controls:2.39%
cases:8.93%
controls:6.48%
55
334
846
8610
32
185
872
8785
—
—
14
18
889
8948
44
211
844
8610
74
534
755
7704
esomeprazole; oral, parenteral
A02BC05 [21600100]
4.5e-01
6.5e-01
5.6e-01
—
1.3e+00
7.6e-01
6.3e-01
cases:7.44%
controls:4.87%
cases:4.31%
controls:2.30%
cases:0.77%
controls:0.45%
—
—
cases:1.44%
controls:0.41%
cases:4.84%
controls:2.34%
cases:10.13%
controls:5.64%
67
436
834
8508
39
206
865
8764
7
40
897
8930
—
13
37
890
8929
43
206
845
8615
84
465
745
7773
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
1.3e+00
2.0e+00
—
—
—
1.5e+00
8.7e-01
cases:1.78%
controls:0.51%
cases:1.99%
controls:0.27%
—
—
—
—
—
—
cases:0.68%
controls:0.16%
cases:1.33%
controls:0.56%
16
46
885
8898
18
24
886
8946
—
—
—
6
14
882
8807
11
46
818
8192
testosterone; oral, parenteral, rectal, sublingual, transdermal
G03BA03 [21602510]
8.7e-01
1.6e+00
2.1e+00
—
-1.0e+50
1.7e+00
1.1e+00
cases:0.67%
controls:0.28%
cases:1.00%
controls:0.20%
cases:0.55%
controls:0.07%
—
—
cases:0.00%
controls:0.11%
cases:1.13%
controls:0.22%
cases:1.09%
controls:0.36%
6
25
895
8919
9
18
895
8952
5
6
899
8964
—
0
10
903
8956
10
19
878
8802
9
30
820
8208
Audiometric test
21727005 [4071702]
1.5e-02
1.6e+00
—
—
—
1.7e+00
6.5e-01
cases:1.00%
controls:0.98%
cases:0.88%
controls:0.18%
—
—
—
—
—
—
cases:1.24%
controls:0.24%
cases:2.41%
controls:1.27%
9
88
892
8856
8
16
896
8954
—
—
—
11
21
877
8800
20
105
809
8133
nortriptyline; oral, parenteral
N06AA10 [21604697]
1.0e+00
1.5e+00
—
—
—
2.0e+00
1.3e+00
cases:1.33%
controls:0.49%
cases:1.00%
controls:0.23%
—
—
—
—
—
—
cases:1.13%
controls:0.16%
cases:2.17%
controls:0.61%
12
44
889
8900
9
21
895
8949
—
—
—
10
14
878
8807
18
50
811
8188
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
4.3e-01
1.0e+00
—
—
—
1.3e+00
8.6e-01
cases:2.11%
controls:1.38%
cases:2.10%
controls:0.76%
—
—
—
—
—
—
cases:2.70%
controls:0.75%
cases:3.74%
controls:1.61%
19
123
882
8821
19
68
885
8902
—
—
—
24
66
864
8755
31
133
798
8105
Other healthcare associate professional
Z3229 [2001311561]
5.8e-01
8.6e-01
—
—
—
1.7e+00
1.5e+00
cases:1.33%
controls:0.75%
cases:0.55%
controls:0.23%
—
—
—
—
—
—
cases:1.13%
controls:0.20%
cases:2.65%
controls:0.63%
12
67
889
8877
5
21
899
8949
—
—
—
10
18
878
8803
22
52
807
8186
prednisolone
A07EA01 [21600653]
5.6e-01
8.4e-01
7.2e-01
—
8.3e-01
1.0e+00
7.2e-01
cases:10.21%
controls:6.13%
cases:5.53%
controls:2.46%
cases:0.77%
controls:0.38%
—
—
cases:1.00%
controls:0.43%
cases:6.87%
controls:2.52%
cases:13.27%
controls:6.94%
92
548
809
8396
50
221
854
8749
7
34
897
8936
—
9
39
894
8927
61
222
827
8599
110
572
719
7666
methylprednisolone; oral, parenteral
H02AB04 [21602732]
7.1e-01
1.2e+00
—
—
—
1.1e+00
8.7e-01
cases:2.55%
controls:1.27%
cases:1.55%
controls:0.49%
—
—
—
—
—
—
cases:1.46%
controls:0.48%
cases:2.53%
controls:1.08%
23
114
878
8830
14
44
890
8926
—
—
—
13
42
875
8779
21
89
808
8149
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
3.2e-01
5.1e-01
8.0e-01
—
1.3e+00
6.1e-01
7.1e-01
cases:9.10%
controls:6.75%
cases:7.41%
controls:4.57%
cases:2.32%
controls:1.06%
—
—
cases:3.32%
controls:0.90%
cases:7.32%
controls:4.13%
cases:16.41%
controls:8.82%
82
604
819
8340
67
410
837
8560
21
95
883
8875
—
30
81
873
8885
65
364
823
8457
136
727
693
7511
prednisolone; oral, parenteral
H02AB06 [21602734]
5.6e-01
8.4e-01
7.2e-01
—
8.3e-01
1.1e+00
6.9e-01
cases:10.21%
controls:6.07%
cases:5.53%
controls:2.46%
cases:0.77%
controls:0.38%
—
—
cases:1.00%
controls:0.43%
cases:6.87%
controls:2.49%
cases:12.91%
controls:6.93%
92
543
809
8401
50
221
854
8749
7
34
897
8936
—
9
39
894
8927
61
220
827
8601
107
571
722
7667
Ultrasound measurement of residual urine
KC1EE [2001305918]
7.7e-01
1.2e+00
—
—
—
1.7e+00
1.5e+00
cases:1.55%
controls:0.73%
cases:0.77%
controls:0.23%
—
—
—
—
—
—
cases:1.24%
controls:0.24%
cases:2.41%
controls:0.56%
14
65
887
8879
7
21
897
8949
—
—
—
11
21
877
8800
20
46
809
8192
topiramate; oral
N03AX11 [21604433]
1.5e+00
1.6e+00
—
—
—
1.0e+00
4.5e-01
cases:1.55%
controls:0.35%
cases:1.11%
controls:0.22%
—
—
—
—
—
—
cases:0.56%
controls:0.20%
cases:0.72%
controls:0.46%
14
31
887
8913
10
20
894
8950
—
—
—
5
18
883
8803
6
38
823
8200
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
6.2e-01
1.0e+00
2.0e+00
—
—
1.0e+00
1.1e+00
cases:2.00%
controls:1.08%
cases:1.11%
controls:0.39%
cases:0.77%
controls:0.10%
—
—
—
—
cases:1.13%
controls:0.41%
cases:2.77%
controls:0.97%
18
97
883
8847
10
35
894
8935
7
9
897
8961
—
—
10
36
878
8785
23
80
806
8158
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
5.8e-01
9.5e-01
—
—
1.5e+00
1.3e+00
8.3e-01
cases:4.11%
controls:2.34%
cases:2.32%
controls:0.91%
—
—
—
—
cases:0.55%
controls:0.12%
cases:2.70%
controls:0.73%
cases:5.79%
controls:2.61%
37
209
864
8735
21
82
883
8888
—
—
5
11
898
8955
24
64
864
8757
48
215
781
8023
Multiple sclerosis
N86 [2002000786]
—
—
—
—
—
—
3.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.33%
controls:0.06%
—
—
—
—
—
—
11
5
818
8233
melatonin; oral
N05CH01 [21604659]
7.9e-01
1.1e+00
1.1e+00
—
9.6e-01
1.1e+00
5.8e-01
cases:2.77%
controls:1.27%
cases:2.32%
controls:0.77%
cases:0.55%
controls:0.18%
—
—
cases:0.55%
controls:0.21%
cases:2.59%
controls:0.84%
cases:4.10%
controls:2.34%
25
114
876
8830
21
69
883
8901
5
16
899
8954
—
5
19
898
8947
23
74
865
8747
34
193
795
8045
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
4.0e-01
7.2e-01
2.4e+00
—
—
6.5e-01
6.2e-01
cases:6.33%
controls:4.34%
cases:2.77%
controls:1.36%
cases:0.88%
controls:0.08%
—
—
—
—
cases:2.82%
controls:1.49%
cases:8.69%
controls:4.87%
57
388
844
8556
25
122
879
8848
8
7
896
8963
—
—
25
131
863
8690
72
401
757
7837
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
4.0e-01
7.2e-01
2.4e+00
—
—
6.5e-01
6.2e-01
cases:6.33%
controls:4.34%
cases:2.77%
controls:1.36%
cases:0.88%
controls:0.08%
—
—
—
—
cases:2.82%
controls:1.49%
cases:8.69%
controls:4.87%
57
388
844
8556
25
122
879
8848
8
7
896
8963
—
—
25
131
863
8690
72
401
757
7837
Internal Medicine
11 [38004456]
3.8e-01
6.9e-01
1.1e+00
—
7.0e-01
5.7e-01
3.6e-01
cases:20.09%
controls:14.69%
cases:12.39%
controls:6.61%
cases:3.32%
controls:1.18%
—
—
cases:2.44%
controls:1.23%
cases:12.39%
controls:7.40%
cases:24.00%
controls:18.05%
181
1314
720
7630
112
593
792
8377
30
106
874
8864
—
22
110
881
8856
110
653
778
8168
199
1487
630
6751
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
1.3e+00
1.7e+00
—
—
—
1.5e+00
9.9e-01
cases:2.22%
controls:0.61%
cases:0.88%
controls:0.16%
—
—
—
—
—
—
cases:0.68%
controls:0.15%
cases:1.69%
controls:0.63%
20
55
881
8889
8
14
896
8956
—
—
—
6
13
882
8808
14
52
815
8186
acetylsalicylic acid; oral
B01AC06 [21600991]
4.5e-01
8.4e-01
—
—
2.0e+00
1.1e+00
3.9e-01
cases:1.78%
controls:1.14%
cases:1.66%
controls:0.72%
—
—
—
—
cases:1.66%
controls:0.23%
cases:2.25%
controls:0.79%
cases:2.41%
controls:1.64%
16
102
885
8842
15
65
889
8905
—
—
15
21
888
8945
20
70
868
8751
20
135
809
8103
INR in Blood by Coagulation assay
34714-6 [3032080]
5.8e-01
6.9e-01
1.1e+00
—
8.6e-01
5.7e-01
6.7e-01
cases:6.55%
controls:3.78%
cases:4.54%
controls:2.33%
cases:1.99%
controls:0.68%
—
—
cases:1.77%
controls:0.76%
cases:3.83%
controls:2.21%
cases:10.25%
controls:5.50%
59
338
842
8606
41
209
863
8761
18
61
886
8909
—
16
68
887
8898
34
195
854
8626
85
453
744
7785
codeine and paracetamol
N02AJ06 [1123647]
2.5e-01
6.0e-01
1.3e+00
—
8.1e-01
7.0e-01
3.9e-01
cases:10.10%
controls:8.04%
cases:5.20%
controls:2.91%
cases:1.88%
controls:0.50%
—
—
cases:1.22%
controls:0.55%
cases:5.41%
controls:2.77%
cases:12.79%
controls:9.04%
91
719
810
8225
47
261
857
8709
17
45
887
8925
—
11
49
892
8917
48
244
840
8577
106
745
723
7493
Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 [3048773]
1.5e-01
5.3e-01
1.1e+00
—
1.4e+00
3.0e-01
9.7e-02
cases:13.65%
controls:12.01%
cases:10.73%
controls:6.60%
cases:1.66%
controls:0.58%
—
—
cases:2.99%
controls:0.74%
cases:8.45%
controls:6.41%
cases:18.46%
controls:17.04%
123
1074
778
7870
97
592
807
8378
15
52
889
8918
—
27
66
876
8900
75
565
813
8256
153
1404
676
6834
Intravenous
ZX120 [2001311495]
7.7e-01
1.2e+00
—
—
—
1.8e+00
1.2e+00
cases:1.44%
controls:0.67%
cases:0.88%
controls:0.27%
—
—
—
—
—
—
cases:1.01%
controls:0.17%
cases:1.81%
controls:0.55%
13
60
888
8884
8
24
896
8946
—
—
—
9
15
879
8806
15
45
814
8193
Other and unspecified abdominal pain
R10.4 [45568113]
4.8e-01
7.9e-01
—
—
1.3e+00
1.2e+00
4.9e-01
cases:7.33%
controls:4.66%
cases:2.88%
controls:1.33%
—
—
—
—
cases:0.55%
controls:0.16%
cases:3.83%
controls:1.16%
cases:8.32%
controls:5.27%
66
417
835
8527
26
119
878
8851
—
—
5
14
898
8952
34
102
854
8719
69
434
760
7804
Optical coherence tomography (OCT) of ocular fundus
CK2X4 [2001301456]
8.0e-01
1.4e+00
—
1.0e+50
—
1.6e+00
8.5e-01
cases:1.11%
controls:0.50%
cases:1.22%
controls:0.30%
—
—
cases:2.10%
controls:0.00%
—
—
cases:1.01%
controls:0.22%
cases:1.93%
controls:0.84%
10
45
891
8899
11
27
893
8943
—
19
0
885
8970
—
9
19
879
8802
16
69
813
8169
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
4.2e-01
8.6e-01
—
—
1.5e+00
6.4e-01
5.5e-01
cases:4.88%
controls:3.28%
cases:3.87%
controls:1.68%
—
—
—
—
cases:1.22%
controls:0.27%
cases:3.60%
controls:1.94%
cases:9.89%
controls:5.96%
44
293
857
8651
35
151
869
8819
—
—
11
24
892
8942
32
171
856
8650
82
491
747
7747
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
1.2e-01
4.1e-01
1.1e+00
—
1.3e+00
3.4e-01
9.8e-02
cases:13.76%
controls:12.41%
cases:10.95%
controls:7.53%
cases:1.99%
controls:0.65%
—
—
cases:3.43%
controls:0.91%
cases:10.14%
controls:7.46%
cases:20.99%
controls:19.41%
124
1110
777
7834
99
675
805
8295
18
58
886
8912
—
31
82
872
8884
90
658
798
8163
174
1599
655
6639
pH of Arterial blood
2744-1 [3019977]
9.2e-01
1.5e+00
—
—
—
1.4e+00
6.1e-01
cases:1.55%
controls:0.63%
cases:1.22%
controls:0.28%
—
—
—
—
—
—
cases:1.13%
controls:0.28%
cases:2.17%
controls:1.19%
14
56
887
8888
11
25
893
8945
—
—
—
10
25
878
8796
18
98
811
8140
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
1.3e-01
4.2e-01
1.1e+00
—
1.3e+00
3.4e-01
8.0e-02
cases:14.10%
controls:12.65%
cases:11.50%
controls:7.90%
cases:1.99%
controls:0.68%
—
—
cases:3.43%
controls:0.91%
cases:10.47%
controls:7.69%
cases:21.11%
controls:19.81%
127
1131
774
7813
104
709
800
8261
18
61
886
8909
—
31
82
872
8884
93
678
795
8143
175
1632
654
6606
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
8.9e-02
9.6e-01
1.5e+00
—
1.8e+00
9.7e-01
8.8e-01
cases:2.33%
controls:2.14%
cases:2.54%
controls:0.99%
cases:0.66%
controls:0.16%
—
—
cases:0.55%
controls:0.09%
cases:2.48%
controls:0.95%
cases:5.31%
controls:2.27%
21
191
880
8753
23
89
881
8881
6
14
898
8956
—
5
8
898
8958
22
84
866
8737
44
187
785
8051
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
1.2e-01
3.8e-01
1.2e+00
—
1.2e+00
2.6e-01
9.3e-02
cases:14.54%
controls:13.10%
cases:12.28%
controls:8.76%
cases:2.43%
controls:0.75%
—
—
cases:3.43%
controls:1.07%
cases:11.04%
controls:8.74%
cases:22.07%
controls:20.51%
131
1172
770
7772
111
786
793
8184
22
67
882
8903
—
31
96
872
8870
98
771
790
8050
183
1690
646
6548
Abdominal ultrasound examination
JN3AE [2001305555]
4.9e-01
5.1e-01
—
—
—
1.7e+00
1.1e+00
cases:1.55%
controls:0.96%
cases:0.55%
controls:0.33%
—
—
—
—
—
—
cases:1.13%
controls:0.22%
cases:2.90%
controls:1.01%
14
86
887
8858
5
30
899
8940
—
—
—
10
19
878
8802
24
83
805
8155
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
1.5e-01
5.4e-01
1.0e+00
—
1.2e+00
2.0e-01
1.4e-01
cases:11.88%
controls:10.39%
cases:11.95%
controls:7.32%
cases:2.10%
controls:0.76%
—
—
cases:2.99%
controls:0.96%
cases:9.35%
controls:7.79%
cases:19.90%
controls:17.76%
107
929
794
8015
108
657
796
8313
19
68
885
8902
—
27
86
876
8880
83
687
805
8134
165
1463
664
6775
Scheduled procedure
ZXD10 [2001311387]
2.5e-01
8.7e-01
—
—
1.8e+00
7.1e-01
4.6e-01
cases:6.10%
controls:4.81%
cases:3.10%
controls:1.32%
—
—
—
—
cases:0.78%
controls:0.12%
cases:2.36%
controls:1.18%
cases:4.83%
controls:3.10%
55
430
846
8514
28
118
876
8852
—
—
7
11
896
8955
21
104
867
8717
40
255
789
7983
Observation for suspected nervous system disorder
Z03.3 [45609903]
1.1e+00
1.5e+00
—
—
1.0e+50
2.7e+00
1.0e+00
cases:1.11%
controls:0.38%
cases:0.66%
controls:0.14%
—
—
—
—
cases:0.55%
controls:0.00%
cases:1.01%
controls:0.07%
cases:1.33%
controls:0.47%
10
34
891
8910
6
13
898
8957
—
—
5
0
898
8966
9
6
879
8815
11
39
818
8199
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
1.3e+00
1.8e+00
—
—
—
1.7e+00
1.4e+00
cases:1.33%
controls:0.37%
cases:0.55%
controls:0.09%
—
—
—
—
—
—
cases:0.68%
controls:0.12%
cases:1.93%
controls:0.50%
12
33
889
8911
5
8
899
8962
—
—
—
6
11
882
8810
16
41
813
8197
salbutamol; inhalant
R03AC02 [21603256]
5.8e-01
5.8e-01
8.1e-01
—
8.5e-01
7.7e-01
7.1e-01
cases:16.76%
controls:10.12%
cases:9.07%
controls:5.27%
cases:1.77%
controls:0.79%
—
—
cases:2.10%
controls:0.91%
cases:10.70%
controls:5.25%
cases:22.07%
controls:12.20%
151
905
750
8039
82
473
822
8497
16
71
888
8899
—
19
82
884
8884
95
463
793
8358
183
1005
646
7233
Migraine with aura [classical migraine]
G43.1 [45562086]
9.0e-01
1.6e+00
—
—
—
1.3e+00
1.1e+00
cases:1.66%
controls:0.68%
cases:1.55%
controls:0.32%
—
—
—
—
—
—
cases:1.13%
controls:0.31%
cases:2.53%
controls:0.89%
15
61
886
8883
14
29
890
8941
—
—
—
10
27
878
8794
21
73
808
8165
amantadine; oral
N04BB01 [21604471]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.06%
—
—
—
—
—
—
7
5
822
8233
Optic neuritis
H46 [45571994]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.06%
—
—
—
—
—
—
7
5
822
8233
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1.1e+00
1.6e+00
—
—
—
1.0e+00
7.2e-01
cases:1.78%
controls:0.63%
cases:1.77%
controls:0.37%
—
—
—
—
—
—
cases:1.01%
controls:0.37%
cases:2.17%
controls:1.07%
16
56
885
8888
16
33
888
8937
—
—
—
9
33
879
8788
18
88
811
8150
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
6.8e-01
9.9e-01
1.1e+00
—
7.3e-01
9.6e-01
4.8e-01
cases:6.10%
controls:3.20%
cases:3.65%
controls:1.38%
cases:0.55%
controls:0.19%
—
—
cases:0.55%
controls:0.27%
cases:3.60%
controls:1.42%
cases:7.24%
controls:4.60%
55
286
846
8658
33
124
871
8846
5
17
899
8953
—
5
24
898
8942
32
125
856
8696
60
379
769
7859
Specific gravity of Urine by Refractometry
5810-7 [3019150]
4.7e-01
3.9e-01
—
—
1.8e+00
8.1e-01
1.2e-01
cases:3.66%
controls:2.31%
cases:1.88%
controls:1.28%
—
—
—
—
cases:0.89%
controls:0.14%
cases:3.27%
controls:1.49%
cases:4.70%
controls:4.18%
33
207
868
8737
17
115
887
8855
—
—
8
13
895
8953
29
131
859
8690
39
344
790
7894
amitriptyline and psycholeptics
N06CA01 [21604789]
6.7e-01
1.5e+00
—
—
—
1.1e+00
8.5e-01
cases:2.00%
controls:1.03%
cases:1.77%
controls:0.41%
—
—
—
—
—
—
cases:1.46%
controls:0.48%
cases:1.69%
controls:0.73%
18
92
883
8852
16
37
888
8933
—
—
—
13
42
875
8779
14
60
815
8178
Stroke/cerebrovascular accident
K90 [2002000617]
—
—
—
—
—
2.6e+00
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.07%
cases:0.72%
controls:0.18%
—
—
—
—
—
8
6
880
8815
6
15
823
8223
mirabegron; oral
G04BD12 [43534790]
1.1e+00
1.1e+00
1.7e+00
—
1.5e+00
1.5e+00
7.0e-01
cases:1.44%
controls:0.49%
cases:1.11%
controls:0.37%
cases:0.55%
controls:0.10%
—
—
cases:0.55%
controls:0.12%
cases:1.46%
controls:0.33%
cases:1.81%
controls:0.91%
13
44
888
8900
10
33
894
8937
5
9
899
8961
—
5
11
898
8955
13
29
875
8792
15
75
814
8163
Bacteria identified in Urine by Culture
630-4 [3026008]
5.3e-01
9.8e-01
—
—
1.4e+00
9.6e-01
6.4e-01
cases:4.00%
controls:2.38%
cases:3.10%
controls:1.18%
—
—
—
—
cases:0.78%
controls:0.19%
cases:3.38%
controls:1.33%
cases:7.12%
controls:3.87%
36
213
865
8731
28
106
876
8864
—
—
7
17
896
8949
30
117
858
8704
59
319
770
7919
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
9.3e-02
1.2e+00
-1.0e+50
—
1.8e+00
1.4e+00
5.7e-01
cases:1.89%
controls:1.72%
cases:1.55%
controls:0.49%
cases:0.00%
controls:0.06%
—
—
cases:0.66%
controls:0.11%
cases:1.58%
controls:0.41%
cases:3.02%
controls:1.74%
17
154
884
8790
14
44
890
8926
0
5
904
8965
—
6
10
897
8956
14
36
874
8785
25
143
804
8095
General anesthesia, balanced
WX408 [2001310808]
5.7e-01
9.2e-01
—
—
—
1.6e+00
7.1e-01
cases:4.22%
controls:2.43%
cases:1.88%
controls:0.76%
—
—
—
—
—
—
cases:2.36%
controls:0.49%
cases:3.14%
controls:1.57%
38
217
863
8727
17
68
887
8902
—
—
—
21
43
867
8778
26
129
803
8109
Medical doctor
Z2221 [2001311556]
6.3e-01
8.8e-01
—
—
1.6e+00
9.9e-01
4.2e-01
cases:5.66%
controls:3.11%
cases:2.43%
controls:1.03%
—
—
—
—
cases:0.55%
controls:0.11%
cases:2.25%
controls:0.85%
cases:3.38%
controls:2.25%
51
278
850
8666
22
92
882
8878
—
—
5
10
898
8956
20
75
868
8746
28
185
801
8053
Short blood count panel - Blood
55429-5 [40758558]
2.9e-01
5.3e-01
6.2e-01
—
1.7e+00
7.9e-01
4.8e-01
cases:4.22%
controls:3.20%
cases:2.77%
controls:1.65%
cases:0.66%
controls:0.36%
—
—
cases:1.33%
controls:0.25%
cases:2.93%
controls:1.35%
cases:5.67%
controls:3.59%
38
286
863
8658
25
148
879
8822
6
32
898
8938
—
12
22
891
8944
26
119
862
8702
47
296
782
7942
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
—
—
—
—
—
2.5e+00
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.06%
cases:0.84%
controls:0.22%
—
—
—
—
—
6
5
882
8816
7
18
822
8220
clobazam; oral
N05BA09 [21604574]
—
—
—
—
—
2.5e+00
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.06%
cases:0.60%
controls:0.10%
—
—
—
—
—
6
5
882
8816
5
8
824
8230
Speech therapy
R4130 [2001310235]
—
2.5e+00
—
—
—
—
—
—
—
cases:0.66%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
6
5
898
8965
—
—
—
—
—
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
4.6e-01
9.9e-01
1.8e+00
—
—
8.9e-01
5.9e-01
cases:4.44%
controls:2.84%
cases:3.65%
controls:1.38%
cases:0.66%
controls:0.11%
—
—
—
—
cases:2.48%
controls:1.03%
cases:5.67%
controls:3.23%
40
254
861
8690
33
124
871
8846
6
10
898
8960
—
—
22
91
866
8730
47
266
782
7972
Headache
N01 [2002000720]
6.4e-01
1.6e+00
—
—
—
3.8e-01
8.8e-01
cases:2.33%
controls:1.24%
cases:1.77%
controls:0.37%
—
—
—
—
—
—
cases:0.68%
controls:0.46%
cases:4.10%
controls:1.74%
21
111
880
8833
16
33
888
8937
—
—
—
6
41
882
8780
34
143
795
8095
epinephrine; parenteral
C01CA24 [21600303]
7.0e-01
1.2e+00
—
—
—
1.2e+00
8.4e-01
cases:1.89%
controls:0.95%
cases:1.33%
controls:0.39%
—
—
—
—
—
—
cases:1.46%
controls:0.43%
cases:2.41%
controls:1.06%
17
85
884
8859
12
35
892
8935
—
—
—
13
38
875
8783
20
87
809
8151
epinephrine
S01EA01 [21603673]
7.0e-01
1.2e+00
—
—
—
1.2e+00
8.4e-01
cases:1.89%
controls:0.95%
cases:1.33%
controls:0.39%
—
—
—
—
—
—
cases:1.46%
controls:0.43%
cases:2.41%
controls:1.06%
17
85
884
8859
12
35
892
8935
—
—
—
13
38
875
8783
20
87
809
8151
Myopia
H52.1 [45533352]
—
1.0e+50
—
1.0e+50
—
—
2.5e+00
—
—
cases:0.66%
controls:0.00%
—
—
cases:0.77%
controls:0.00%
—
—
—
—
cases:1.69%
controls:0.15%
—
6
0
898
8970
—
7
0
897
8970
—
—
14
12
815
8226
Snapping jaw
K07.60 [2000502791]
1.3e+00
—
—
—
—
—
1.2e+00
cases:1.33%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
cases:1.69%
controls:0.53%
12
33
889
8911
—
—
—
—
—
14
44
815
8194
Differential panel - Cerebral spinal fluid
29584-0 [3016018]
—
—
—
—
1.0e+50
—
2.4e+00
—
—
—
—
—
—
—
—
cases:0.55%
controls:0.00%
—
—
cases:0.97%
controls:0.08%
—
—
—
—
5
0
898
8966
—
8
7
821
8231
Pain localized to other parts of lower abdomen
R10.3 [45534426]
6.7e-01
7.2e-01
—
—
—
1.1e+00
6.8e-01
cases:4.33%
controls:2.27%
cases:1.77%
controls:0.87%
—
—
—
—
—
—
cases:2.03%
controls:0.69%
cases:6.03%
controls:3.14%
39
203
862
8741
16
78
888
8892
—
—
—
18
61
870
8760
50
259
779
7979
Uroflowmetry
44856007 [4261340]
9.1e-01
1.3e+00
—
—
—
1.3e+00
1.5e+00
cases:2.44%
controls:1.00%
cases:1.11%
controls:0.29%
—
—
—
—
—
—
cases:1.24%
controls:0.35%
cases:3.26%
controls:0.73%
22
89
879
8855
10
26
894
8944
—
—
—
11
31
877
8790
27
60
802
8178
zopiclone; oral
N05CF01 [21604654]
4.9e-01
6.6e-01
1.9e-01
—
7.9e-01
6.8e-01
5.7e-01
cases:6.55%
controls:4.11%
cases:4.54%
controls:2.40%
cases:0.88%
controls:0.74%
—
—
cases:1.22%
controls:0.56%
cases:4.84%
controls:2.51%
cases:7.96%
controls:4.66%
59
368
842
8576
41
215
863
8755
8
66
896
8904
—
11
50
892
8916
43
221
845
8600
66
384
763
7854
Chronic maxillary sinusitis
J32.0 [45586667]
1.2e+00
1.1e+00
—
—
—
—
1.2e+00
cases:1.55%
controls:0.48%
cases:0.55%
controls:0.19%
—
—
—
—
—
—
—
—
cases:2.17%
controls:0.67%
14
43
887
8901
5
17
899
8953
—
—
—
—
18
55
811
8183
quetiapine; oral
N05AH04 [21604544]
8.3e-01
6.4e-01
1.0e+00
—
7.5e-01
7.9e-01
7.2e-01
cases:4.00%
controls:1.78%
cases:2.32%
controls:1.24%
cases:1.11%
controls:0.39%
—
—
cases:0.78%
controls:0.37%
cases:3.04%
controls:1.41%
cases:5.31%
controls:2.66%
36
159
865
8785
21
111
883
8859
10
35
894
8935
—
7
33
896
8933
27
124
861
8697
44
219
785
8019
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
7.5e-01
8.6e-01
—
—
—
1.4e+00
9.1e-01
cases:2.11%
controls:1.01%
cases:1.00%
controls:0.42%
—
—
—
—
—
—
cases:2.14%
controls:0.53%
cases:2.90%
controls:1.19%
19
90
882
8854
9
38
895
8932
—
—
—
19
47
869
8774
24
98
805
8140
Appearance of Cerebral spinal fluid
10333-3 [3023410]
1.6e+00
—
—
—
1.0e+50
—
2.3e+00
cases:0.67%
controls:0.13%
—
—
—
—
—
—
cases:0.78%
controls:0.00%
—
—
cases:1.21%
controls:0.12%
6
12
895
8932
—
—
—
7
0
896
8966
—
10
10
819
8228
Mixed specific developmental disorders
F83 [45595922]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.10%
—
—
—
—
—
—
8
8
821
8230
Other visual field testing
CS494 [2001301478]
—
—
—
1.0e+50
—
—
2.3e+00
—
—
—
—
—
—
cases:0.66%
controls:0.00%
—
—
—
—
cases:0.97%
controls:0.10%
—
—
—
6
0
898
8970
—
—
8
8
821
8230
Parkinson's disease and comparable movement disrorders
110 [2001600110]
2.3e+00
—
—
—
—
—
—
cases:0.89%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
8
8
893
8936
—
—
—
—
—
—
buprenorphine; implant, parenteral, sublingual
N07BC01 [21604826]
2.3e+00
—
—
—
—
—
—
cases:0.78%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
7
7
894
8937
—
—
—
—
—
—
Cervicocranial syndrome
M53.0 [45562750]
4.9e-01
2.3e+00
—
—
—
1.1e+00
5.7e-01
cases:0.89%
controls:0.55%
cases:0.77%
controls:0.08%
—
—
—
—
—
—
cases:0.68%
controls:0.23%
cases:0.97%
controls:0.55%
8
49
893
8895
7
7
897
8963
—
—
—
6
20
882
8801
8
45
821
8193
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
4.7e-01
1.1e+00
—
—
1.8e+00
1.2e+00
5.5e-01
cases:3.33%
controls:2.10%
cases:2.21%
controls:0.77%
—
—
—
—
cases:0.66%
controls:0.11%
cases:2.70%
controls:0.82%
cases:5.55%
controls:3.29%
30
188
871
8756
20
69
884
8901
—
—
6
10
897
8956
24
72
864
8749
46
271
783
7967
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
3.3e-01
4.8e-01
—
—
1.5e+00
7.3e-01
3.6e-01
cases:3.77%
controls:2.75%
cases:2.32%
controls:1.45%
—
—
—
—
cases:1.11%
controls:0.25%
cases:3.49%
controls:1.71%
cases:6.39%
controls:4.56%
34
246
867
8698
21
130
883
8840
—
—
10
22
893
8944
31
151
857
8670
53
376
776
7862
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
3.3e-01
4.5e-01
4.4e-01
—
1.6e+00
5.8e-01
2.7e-01
cases:6.22%
controls:4.53%
cases:3.98%
controls:2.59%
cases:0.55%
controls:0.36%
—
—
cases:1.77%
controls:0.35%
cases:5.18%
controls:2.98%
cases:10.74%
controls:8.41%
56
405
845
8539
36
232
868
8738
5
32
899
8938
—
16
31
887
8935
46
263
842
8558
89
693
740
7545
platelet aggregation inhibitors excl. heparin - combinations
B01AC30 [21601005]
4.4e-01
5.1e-01
—
—
2.2e+00
1.0e+00
3.1e-01
cases:0.78%
controls:0.50%
cases:0.66%
controls:0.40%
—
—
—
—
cases:1.11%
controls:0.12%
cases:1.24%
controls:0.44%
cases:0.84%
controls:0.62%
7
45
894
8899
6
36
898
8934
—
—
10
11
893
8955
11
39
877
8782
7
51
822
8187
acetylsalicylic acid, combinations excl. psycholeptics
N02BA51 [21604320]
4.4e-01
5.1e-01
—
—
2.2e+00
1.0e+00
3.1e-01
cases:0.78%
controls:0.50%
cases:0.66%
controls:0.40%
—
—
—
—
cases:1.11%
controls:0.12%
cases:1.24%
controls:0.44%
cases:0.84%
controls:0.62%
7
45
894
8899
6
36
898
8934
—
—
10
11
893
8955
11
39
877
8782
7
51
822
8187
citalopram; oral, parenteral
N06AB04 [21604712]
6.7e-01
4.8e-01
7.2e-01
—
5.9e-01
7.5e-01
7.9e-01
cases:4.88%
controls:2.56%
cases:2.43%
controls:1.52%
cases:0.88%
controls:0.43%
—
—
cases:0.66%
controls:0.37%
cases:3.27%
controls:1.56%
cases:6.15%
controls:2.90%
44
229
857
8715
22
136
882
8834
8
39
896
8931
—
6
33
897
8933
29
138
859
8683
51
239
778
7999
Cystoscopy
UKC02 [2001306005]
1.0e+00
1.2e+00
—
—
—
9.1e-01
1.2e+00
cases:2.44%
controls:0.88%
cases:1.11%
controls:0.32%
—
—
—
—
—
—
cases:0.90%
controls:0.36%
cases:2.77%
controls:0.87%
22
79
879
8865
10
29
894
8941
—
—
—
8
32
880
8789
23
72
806
8166
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
3.5e-01
4.3e-01
4.4e-01
—
1.6e+00
5.9e-01
2.9e-01
cases:6.44%
controls:4.64%
cases:3.98%
controls:2.63%
cases:0.55%
controls:0.36%
—
—
cases:1.77%
controls:0.36%
cases:5.41%
controls:3.07%
cases:11.10%
controls:8.56%
58
415
843
8529
36
236
868
8734
5
32
899
8938
—
16
32
887
8934
48
271
840
8550
92
705
737
7533
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
4.6e-01
7.0e-01
3.8e-01
—
7.0e-01
5.9e-01
4.6e-01
cases:13.32%
controls:8.88%
cases:10.62%
controls:5.56%
cases:1.44%
controls:0.99%
—
—
cases:1.99%
controls:1.00%
cases:9.46%
controls:5.49%
cases:17.49%
controls:11.82%
120
794
781
8150
96
499
808
8471
13
89
891
8881
—
18
90
885
8876
84
484
804
8337
145
974
684
7264
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
4.3e-01
1.2e+00
—
—
—
1.0e+00
2.7e-01
cases:2.77%
controls:1.82%
cases:2.32%
controls:0.72%
—
—
—
—
—
—
cases:1.69%
controls:0.62%
cases:3.26%
controls:2.50%
25
163
876
8781
21
65
883
8905
—
—
—
15
55
873
8766
27
206
802
8032
CD3 cells/Lymphocytes in Blood
90304-7 [1175426]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.10%
—
—
—
—
—
—
7
8
822
8230
Unspecified urinary incontinence
R32 [45606803]
2.2e+00
—
—
—
—
—
2.3e+00
cases:0.78%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.06%
7
8
894
8936
—
—
—
—
—
5
5
824
8233
Cardiac ultrasound examination through oesophagus
FM1BE [2001303285]
8.3e-01
2.2e+00
—
—
—
—
—
cases:0.67%
controls:0.29%
cases:0.77%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
6
26
895
8918
7
8
897
8962
—
—
—
—
—
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
6.2e-01
7.4e-01
1.0e+00
—
3.8e-01
8.0e-01
4.0e-01
cases:9.43%
controls:5.29%
cases:4.31%
controls:2.10%
cases:0.88%
controls:0.32%
—
—
cases:0.55%
controls:0.38%
cases:4.84%
controls:2.24%
cases:9.65%
controls:6.68%
85
473
816
8471
39
188
865
8782
8
29
896
8941
—
5
34
898
8932
43
198
845
8623
80
550
749
7688
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
N04BA03 [21604466]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.72%
controls:0.08%
—
—
—
—
—
—
6
7
823
8231
Aspergillus fumigatus IgE Ab [Units/volume] in Serum
6025-1 [3011951]
-1.0e+50
—
—
—
—
—
2.1e+00
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.72%
controls:0.08%
0
7
901
8937
—
—
—
—
—
6
7
823
8231
Physiologic investigation of micturition
XKD06 [2001306098]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.72%
controls:0.08%
—
—
—
—
—
—
6
7
823
8231
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
80721-4 [21493690]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.72%
controls:0.08%
—
—
—
—
—
—
6
7
823
8231
Parkinsonism
N87 [2002000787]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.72%
controls:0.08%
—
—
—
—
—
—
6
7
823
8231
Hypermobility syndrome
M35.7 [45601437]
2.1e+00
—
—
—
—
—
—
cases:0.67%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
895
8937
—
—
—
—
—
—
Decompression of lumbar spinal canal and nerve roots
ABC56 [2001300479]
2.1e+00
—
—
—
—
—
—
cases:0.67%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
895
8937
—
—
—
—
—
—
Other rehabilitation service
R5599 [2001310270]
2.1e+00
—
—
—
—
—
—
cases:0.67%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
895
8937
—
—
—
—
—
—
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
9.2e-01
8.6e-01
—
—
—
2.1e+00
8.6e-01
cases:1.22%
controls:0.49%
cases:0.55%
controls:0.23%
—
—
—
—
—
—
cases:1.24%
controls:0.15%
cases:1.57%
controls:0.67%
11
44
890
8900
5
21
899
8949
—
—
—
11
13
877
8808
13
55
816
8183
Counselling/guidance promoting independent living
SPAT1222 [2001700323]
2.5e-01
1.2e+00
1.6e+00
—
1.6e+00
1.3e+00
8.3e-01
cases:1.00%
controls:0.78%
cases:1.22%
controls:0.38%
cases:0.55%
controls:0.11%
—
—
cases:0.55%
controls:0.11%
cases:1.58%
controls:0.44%
cases:2.77%
controls:1.23%
9
70
892
8874
11
34
893
8936
5
10
899
8960
—
5
10
898
8956
14
39
874
8782
23
101
806
8137
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
5.0e-01
5.9e-01
1.6e+00
—
—
7.3e-01
4.5e-01
cases:6.66%
controls:4.14%
cases:3.87%
controls:2.19%
cases:1.11%
controls:0.22%
—
—
—
—
cases:2.93%
controls:1.44%
cases:8.08%
controls:5.32%
60
370
841
8574
35
196
869
8774
10
20
894
8950
—
—
26
127
862
8694
67
438
762
7800
Cathetrisation of vein
TPH04 [2001309597]
5.0e-01
1.2e+00
—
—
-1.0e+50
9.9e-01
8.6e-01
cases:2.33%
controls:1.42%
cases:1.88%
controls:0.55%
—
—
—
—
cases:0.00%
controls:0.06%
cases:1.24%
controls:0.46%
cases:3.62%
controls:1.57%
21
127
880
8817
17
49
887
8921
—
—
0
5
903
8961
11
41
877
8780
30
129
799
8109
trospium; oral
G04BD09 [21602642]
—
—
—
—
—
2.3e+00
2.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.06%
cases:1.09%
controls:0.13%
—
—
—
—
—
5
5
883
8816
9
11
820
8227
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
4.9e-01
6.0e-01
—
—
2.1e+00
6.5e-01
3.7e-01
cases:3.33%
controls:2.07%
cases:2.32%
controls:1.29%
—
—
—
—
cases:1.00%
controls:0.12%
cases:2.93%
controls:1.55%
cases:5.91%
controls:4.16%
30
185
871
8759
21
116
883
8854
—
—
9
11
894
8955
26
137
862
8684
49
343
780
7895
Exploration of knee joint, arthroscopic
NGA30 [2001308091]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.45%
controls:0.18%
—
—
—
—
—
—
12
15
817
8223
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
O99.3 [45606675]
2.1e+00
—
—
—
—
—
1.7e+00
cases:0.89%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:0.72%
controls:0.13%
8
10
893
8934
—
—
—
—
—
6
11
823
8227
CD3 cells [#/volume] in Blood
8122-4 [3011412]
—
—
—
—
—
2.1e+00
2.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.07%
cases:0.84%
controls:0.11%
—
—
—
—
—
5
6
883
8815
7
9
822
8229
Eating disorder, unspecified
F50.9 [45547713]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.11%
—
—
—
—
—
—
7
9
822
8229
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
6.0e-01
9.0e-01
—
—
1.2e+00
6.3e-01
5.4e-01
cases:4.77%
controls:2.67%
cases:2.32%
controls:0.96%
—
—
—
—
cases:0.55%
controls:0.17%
cases:2.25%
controls:1.21%
cases:6.51%
controls:3.91%
43
239
858
8705
21
86
883
8884
—
—
5
15
898
8951
20
107
868
8714
54
322
775
7916
Upper gastrointestinal surgery
106 [44777669]
6.6e-01
5.9e-01
—
—
1.4e+00
7.7e-01
6.0e-01
cases:8.99%
controls:4.85%
cases:3.10%
controls:1.74%
—
—
—
—
cases:1.00%
controls:0.26%
cases:3.83%
controls:1.80%
cases:10.62%
controls:6.12%
81
434
820
8510
28
156
876
8814
—
—
9
23
894
8943
34
159
854
8662
88
504
741
7734
Complex partial seizures with only alteration of consciousness
G40.20 [2000502139]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.09%
controls:0.15%
—
—
—
—
—
—
9
12
820
8226
CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
14135-8 [3001405]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.72%
controls:0.10%
—
—
—
—
—
—
6
8
823
8230
CD3-CD16+CD56+ (Natural killer) cells/cells in Blood
8112-5 [3027831]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.72%
controls:0.10%
—
—
—
—
—
—
6
8
823
8230
Lower leg X-ray examination
NG4AA [2001308083]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.72%
controls:0.10%
—
—
—
—
—
—
6
8
823
8230
Pelvic and perineal pain
R10.2 [45548947]
2.0e+00
—
—
—
—
—
—
cases:0.67%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
895
8936
—
—
—
—
—
—
Complicated migraine
G43.3 [45576576]
-1.0e+50
2.0e+00
—
—
—
2.3e+00
1.2e+00
cases:0.00%
controls:0.13%
cases:0.66%
controls:0.09%
—
—
—
—
—
—
cases:0.56%
controls:0.06%
cases:0.84%
controls:0.27%
0
12
901
8932
6
8
898
8962
—
—
—
5
5
883
8816
7
22
822
8216
Psychiatric treatment plan, standard
ICB01 [2001304098]
2.0e+00
—
—
—
—
1.4e+00
—
cases:0.89%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.79%
controls:0.19%
—
—
8
11
893
8933
—
—
—
—
7
17
881
8804
—
Visual field defects
H53.4 [45557469]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.21%
controls:0.17%
—
—
—
—
—
—
10
14
819
8224
Malaise and fatigue
R53 [45553741]
4.5e-01
1.3e+00
—
—
—
5.7e-01
6.7e-01
cases:2.55%
controls:1.64%
cases:2.21%
controls:0.61%
—
—
—
—
—
—
cases:1.35%
controls:0.77%
cases:5.07%
controls:2.67%
23
147
878
8797
20
55
884
8915
—
—
—
12
68
876
8753
42
220
787
8018
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
4.2e-01
9.7e-01
1.9e+00
—
—
9.8e-01
5.4e-01
cases:2.77%
controls:1.84%
cases:2.54%
controls:0.98%
cases:0.66%
controls:0.10%
—
—
—
—
cases:2.03%
controls:0.77%
cases:4.22%
controls:2.51%
25
165
876
8779
23
88
881
8882
6
9
898
8961
—
—
18
68
870
8753
35
207
794
8031
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
182 [2001600181]
2.1e+00
—
—
—
—
—
1.9e+00
cases:0.55%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.12%
5
6
896
8938
—
—
—
—
—
7
10
822
8228
Other specified urinary incontinence
N39.4 [45577525]
7.9e-01
1.3e+00
—
—
—
1.9e+00
8.6e-01
cases:0.67%
controls:0.30%
cases:0.55%
controls:0.16%
—
—
—
—
—
—
cases:0.79%
controls:0.11%
cases:1.45%
controls:0.62%
6
27
895
8917
5
14
899
8956
—
—
—
7
10
881
8811
12
51
817
8187
Pain in limb
M79.6 [45587063]
5.8e-01
6.1e-01
1.7e+00
—
—
7.6e-01
6.0e-01
cases:4.99%
controls:2.85%
cases:2.32%
controls:1.28%
cases:0.66%
controls:0.12%
—
—
—
—
cases:2.93%
controls:1.39%
cases:8.32%
controls:4.75%
45
255
856
8689
21
115
883
8855
6
11
898
8959
—
—
26
123
862
8698
69
391
760
7847
General anaesthesia
WX402 [2001310806]
8.5e-01
1.1e+00
—
—
—
5.1e-01
7.9e-01
cases:2.11%
controls:0.92%
cases:1.77%
controls:0.57%
—
—
—
—
—
—
cases:0.68%
controls:0.41%
cases:3.86%
controls:1.80%
19
82
882
8862
16
51
888
8919
—
—
—
6
36
882
8785
32
148
797
8090
doxycycline; oral, parenteral
J01AA02 [21602800]
4.0e-01
5.4e-01
9.7e-01
—
9.7e-01
6.6e-01
3.3e-01
cases:21.64%
controls:15.59%
cases:6.97%
controls:4.20%
cases:1.00%
controls:0.38%
—
—
cases:1.00%
controls:0.38%
cases:7.21%
controls:3.87%
cases:17.73%
controls:13.46%
195
1394
706
7550
63
377
841
8593
9
34
895
8936
—
9
34
894
8932
64
341
824
8480
147
1109
682
7129
Hearing complaint
H02 [2002000476]
3.5e-01
1.9e+00
—
—
—
—
7.8e-02
cases:0.78%
controls:0.55%
cases:0.88%
controls:0.13%
—
—
—
—
—
—
—
—
cases:1.21%
controls:1.12%
7
49
894
8895
8
12
896
8958
—
—
—
—
10
92
819
8146
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
6.8e-01
1.0e+00
—
—
—
1.1e+00
8.1e-01
cases:1.66%
controls:0.85%
cases:1.11%
controls:0.40%
—
—
—
—
—
—
cases:1.46%
controls:0.50%
cases:3.86%
controls:1.76%
15
76
886
8868
10
36
894
8934
—
—
—
13
44
875
8777
32
145
797
8093
Right side
ZXA00 [2001311346]
1.5e-01
1.0e+00
—
—
-1.0e+50
8.4e-01
8.5e-01
cases:2.44%
controls:2.10%
cases:1.66%
controls:0.59%
—
—
—
—
cases:0.00%
controls:0.06%
cases:1.13%
controls:0.49%
cases:3.98%
controls:1.75%
22
188
879
8756
15
53
889
8917
—
—
0
5
903
8961
10
43
878
8778
33
144
796
8094
Depressive episode, unspecified
F32.9 [45571760]
9.9e-01
4.7e-01
—
—
—
1.2e+00
9.0e-01
cases:2.89%
controls:1.10%
cases:0.55%
controls:0.35%
—
—
—
—
—
—
cases:1.24%
controls:0.36%
cases:3.62%
controls:1.51%
26
98
875
8846
5
31
899
8939
—
—
—
11
32
877
8789
30
124
799
8114
12 lead EKG panel
34534-8 [3044889]
3.7e-01
6.1e-01
9.7e-01
—
1.3e+00
4.4e-01
3.2e-01
cases:10.77%
controls:7.67%
cases:7.19%
controls:4.06%
cases:1.11%
controls:0.42%
—
—
cases:1.99%
controls:0.57%
cases:5.74%
controls:3.78%
cases:14.48%
controls:10.95%
97
686
804
8258
65
364
839
8606
10
38
894
8932
—
18
51
885
8915
51
333
837
8488
120
902
709
7336
Persistent somatoform pain disorder
F45.4 [45605498]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.13%
—
—
—
—
—
—
7
11
822
8227
codeine and ibuprofen
N02AJ08 [1123631]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.13%
—
—
—
—
—
—
7
11
822
8227
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
1.2e+00
1.8e+00
—
—
—
1.4e+00
4.8e-01
cases:0.89%
controls:0.28%
cases:0.77%
controls:0.12%
—
—
—
—
—
—
cases:0.68%
controls:0.17%
cases:0.84%
controls:0.52%
8
25
893
8919
7
11
897
8959
—
—
—
6
15
882
8806
7
43
822
8195
Tension-type headache
G44.2 [45581495]
7.2e-01
1.8e+00
2.1e+00
—
—
1.3e+00
6.7e-01
cases:2.22%
controls:1.10%
cases:1.33%
controls:0.21%
cases:0.55%
controls:0.07%
—
—
—
—
cases:1.01%
controls:0.27%
cases:2.41%
controls:1.25%
20
98
881
8846
12
19
892
8951
5
6
899
8964
—
—
9
24
879
8797
20
103
809
8135

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
395
2062
2.60
42.53
2.5
2.0
185.00
183.51
u/l
0.01
380
1964
48
51
9.87
40.96
1.2
1.1
1.18
0.11
nmol/l
—
14
8
90
197
4.95
39.10
1.6
1.6
1868.11
677.27
e6/l
0.29
72
150
88
194
4.91
37.89
1.6
1.6
172.14
18.19
e6/l
0.50
66
140
87
192
4.90
37.40
1.3
1.6
3.47
3.65
mmol/l
1.07
81
182
81
174
5.01
35.92
1.6
1.7
—
—
—
0
0
51
78
6.86
32.19
1.2
1.2
35.83
41.21
mg/l
0.31
42
62
49
73
7.03
31.68
1.1
1.1
219.34
240.71
mg/l
0.30
44
62
45
62
7.58
31.18
1.2
1.2
0.77
0.64
ratio
0.32
25
35
77
188
4.38
29.12
4.9
7.4
1.11
1.27
mmol/l
1.13
71
159
53
96
5.80
28.31
1.8
2.0
—
—
—
0
0
226
1070
2.47
28.09
2.3
2.3
28.39
29.47
s
2.61
216
1039
473
3090
2.09
26.19
5.5
4.7
36.84
36.72
g/l
0.20
451
2926
115
418
3.00
23.80
3.0
3.1
154.59
162.59
ng/l
0.07
109
373
46
86
5.58
23.74
1.8
1.8
—
—
—
0
0
324
1957
2.01
21.11
4.4
3.4
1.02
1.02
kg/l
1.88
219
1284
596
4427
1.97
21.00
7.1
4.9
6.26
6.45
mmol/l
1.73
534
4064
504
3548
1.92
20.76
9.8
6.8
1.21
1.21
mmol/l
0.26
454
3102
150
669
2.48
20.73
2.9
2.8
10.31
10.39
g/l
0.10
138
623
458
3164
1.89
19.59
8.6
6.4
1.21
1.21
mmol/l
0.28
438
2950
333
2105
1.91
18.48
4.3
3.7
7.40
7.40
ph
0.19
250
1480
95
358
2.84
18.31
8.0
11.3
16.66
15.95
%
1.67
90
341
351
2270
1.88
18.06
4.0
2.7
—
—
—
0
0
234
1328
2.02
17.68
4.2
3.6
75.48
453.58
ng/l
3.35
152
872
360
2384
1.84
16.91
3.3
2.5
61.05
61.09
u/l
0.00
338
2227
28
20
14.40
16.87
1.1
1.0
—
—
—
0
0
664
5350
1.85
15.59
6.3
4.2
66.29
1024.52
e6/l
—
7
63
92
372
2.64
15.45
6.8
7.7
23.81
24.21
mmol/l
0.53
86
351
124
590
2.27
14.59
8.0
9.2
123.05
121.49
g/l
0.38
119
577
142
715
2.16
14.54
7.7
9.0
7.42
7.42
ph
0.67
90
387
139
699
2.16
14.27
7.7
9.1
0.95
0.78
mmol/l
0.22
104
577
141
714
2.15
14.22
7.7
8.9
4.91
5.10
kpa
1.68
132
684
141
714
2.15
14.22
7.7
8.9
13.07
12.75
kpa
0.29
133
685
564
4400
1.72
14.01
8.1
6.5
0.20
0.18
e9/l
0.80
520
3878
179
996
1.99
13.98
1.7
1.7
1092.73
1164.41
nmol/l
0.51
143
773
559
4363
1.71
13.74
7.8
6.2
1.98
1.99
e9/l
0.04
519
3896
365
2541
1.72
13.73
3.3
2.7
0.00
0.06
—
8
34
547
4251
1.70
13.60
7.8
6.2
0.55
0.55
e9/l
0.09
498
3684
547
4257
1.70
13.47
7.9
6.2
0.04
0.04
e9/l
0.41
500
3692
414
2997
1.69
13.37
13.6
10.2
1.15
1.16
inr
0.15
354
2465
380
2689
1.70
13.37
8.1
6.2
—
—
—
0
0
391
2793
1.69
13.24
4.1
3.2
27.42
30.34
u/l
1.21
368
2644
563
4440
1.68
12.96
4.6
3.5
0.00
3.08
estimate
0.80
90
945
81
337
2.54
12.81
5.6
5.8
—
—
—
0
0
163
910
1.96
12.52
5.2
6.2
1.06
1.08
mmol/l
0.45
155
846
195
1170
1.84
11.98
3.4
3.5
0.83
0.82
mmol/l
0.65
186
1123
583
4712
1.64
11.53
11.3
9.0
4.02
4.02
e9/l
0.01
529
4107
555
4468
1.61
10.83
4.6
3.5
0.03
0.35
estimate
0.45
88
895
500
3930
1.59
10.77
8.1
6.3
8.37
8.47
%
0.38
484
3714
496
3930
1.57
10.03
8.0
6.2
2.87
2.78
%
0.40
479
3708
461
3593
1.56
10.03
4.2
3.1
6.23
6.21
ph
0.10
256
2027
412
3132
1.57
9.99
2.2
2.0
96.38
96.30
pmol/l
0.01
218
1697
492
3896
1.56
9.94
6.5
6.1
9.75
10.99
umol/l
2.91
470
3708
138
787
1.89
9.83
1.3
1.2
—
—
—
0
0
286
2012
1.61
9.57
1.7
1.6
21.94
20.22
nmol/l
1.01
262
1753
854
7822
2.20
9.53
21.9
14.2
139.78
139.59
mmol/l
1.75
844
7663
492
3922
1.54
9.47
8.2
6.2
0.63
0.67
%
1.09
473
3688
115
625
1.96
9.45
8.4
9.7
96.68
95.78
%
0.90
110
606
505
4055
1.54
9.35
8.0
6.2
29.59
29.24
%
0.31
491
3878
261
1806
1.62
9.31
4.8
4.1
—
—
—
0
0
540
4404
1.54
9.28
4.6
3.5
0.00
0.00
estimate
0.50
88
938
674
5785
1.61
9.20
8.5
7.4
78.98
77.55
u/l
0.26
644
5499
853
7832
2.14
9.09
22.0
14.3
3.92
3.93
mmol/l
0.55
842
7656
105
568
1.96
8.73
2.5
2.4
9.20
18.91
au/ml
—
9
64
494
3988
1.51
8.64
7.9
6.1
55.66
56.42
%
0.77
485
3829
141
852
1.77
8.27
2.3
2.1
379.91
384.53
nmol/l
0.10
130
798
126
738
1.82
8.20
8.0
4.6
7.39
7.38
ph
0.73
81
412
20
32
6.36
8.04
1.3
1.5
122.30
136.38
nmol/l
0.62
20
32
288
2111
1.53
7.77
2.6
2.2
2.41
2.69
mg/l
1.37
262
1832
95
522
1.91
7.54
4.3
4.0
82.94
72.68
ng/l
0.51
85
477
18
41
4.46
7.45
2.4
3.0
0.21
0.27
e9/l
—
6
23
119
717
1.76
7.02
8.0
4.6
2.01
1.67
mmol/l
0.63
109
613
418
3361
1.44
6.88
4.5
3.3
0.05
0.03
estimate
0.26
75
798
75
393
1.99
6.84
2.0
1.2
—
—
—
0
0
178
1206
1.59
6.70
2.4
2.3
13.15
14.12
umol/l
1.15
171
1125
734
6593
1.55
6.65
5.6
4.5
14.61
14.48
pmol/l
0.76
702
6144
467
3869
1.42
6.34
3.4
2.7
—
—
estimate
—
0
0
92
534
1.80
6.16
2.4
1.9
1.07
1.31
g/l
1.50
85
499
85
488
1.82
5.90
2.8
2.6
66.63
67.14
g/l
0.29
79
459
649
5737
1.44
5.90
3.9
3.1
35.93
38.45
u/l
0.49
620
5503
142
940
1.60
5.85
1.9
1.6
—
—
—
0
0
163
1116
1.56
5.82
2.4
2.3
2.47
2.39
g/l
0.95
157
1029
103
634
1.70
5.63
8.7
4.1
4.72
4.65
kpa
0.13
103
614
24
82
2.98
5.60
1.4
1.2
—
—
nmol/l
—
0
0
385
3135
1.39
5.53
1.9
1.9
1.39
1.33
mmol/l
0.79
361
2725
319
2516
1.41
5.53
3.3
3.2
2.33
2.35
mmol/l
2.26
297
2333
303
2382
1.40
5.31
1.4
1.4
0.53
2.01
u/ml
4.69
76
670
56
291
1.98
5.27
2.4
2.2
1.98
4.00
iu/l
3.07
31
119
307
2423
1.40
5.25
5.9
5.7
—
—
—
0
0
876
8332
1.97
5.20
18.6
11.6
—
—
—
0
0
320
2558
1.38
5.03
3.6
2.9
0.04
0.05
estimate
0.07
77
787
813
7594
1.58
4.94
6.7
5.3
1.71
1.81
mu/l
2.15
787
7192
55
292
1.94
4.89
1.1
1.5
—
13.10
—
0
7
194
1427
1.45
4.86
1.8
1.6
438.73
20870689.19
pmol/l
1.32
168
1241
520
4507
1.35
4.79
3.9
3.2
86.68
87.14
ug/l
0.02
498
4276
37
171
2.21
4.74
1.2
1.2
—
—
—
0
0
875
8354
1.88
4.60
22.6
15.6
70.54
71.23
umol/l
0.25
870
8266
147
1035
1.50
4.58
2.9
3.0
4.06
5.07
e9/l
1.51
135
936
143
1002
1.51
4.56
2.4
2.4
21.85
23.61
%
0.86
137
942
94
601
1.63
4.47
3.2
3.7
4.58
4.65
pmol/l
0.32
83
545
149
1060
1.48
4.41
2.0
1.9
—
—
—
0
0
111
742
1.56
4.38
3.0
2.8
1.77
1.76
%
0.04
103
669
430
3655
1.33
4.36
2.8
2.5
75.79
74.13
nmol/l
0.60
395
3391
64
371
1.78
4.35
2.1
2.4
—
—
—
0
0
214
1640
1.40
4.23
1.4
1.3
17.60
30.24
iu/ml
2.23
61
465
843
8003
1.60
4.06
19.6
13.0
20.83
20.91
mg/l
0.02
693
6445
94
617
1.58
4.02
13.5
9.4
—
—
—
0
0
175
1307
1.42
4.00
2.3
2.5
69.48
99.69
ug/g
1.56
134
1021
196
1494
1.40
3.98
1.3
1.3
1.72
10.52
u/ml
6.61
69
613
871
8343
1.75
3.97
13.3
10.3
24.81
25.52
u/l
0.75
854
8146
108
735
1.53
3.95
3.4
2.3
5089.42
5760.53
u/l
0.10
48
322
86
556
1.60
3.93
1.8
1.7
285.31
301.78
mu/l
0.17
81
495
32
152
2.14
3.88
3.0
3.4
1.41
1.80
ratio
0.34
18
86
59
347
1.75
3.85
11.3
3.5
0.63
0.62
%
0.12
59
347
31
146
2.16
3.84
2.3
1.9
13.68
13.08
%
0.98
31
146
21
83
2.57
3.82
1.4
1.3
2.84
2.87
g/l
0.04
14
61
21
83
2.57
3.82
1.4
1.3
6.47
5.80
g/l
0.55
14
62
21
83
2.57
3.82
1.4
1.3
0.37
0.36
g/l
0.02
14
60
59
349
1.74
3.78
2.8
2.9
20.72
20.97
s
0.19
50
311
29
134
2.20
3.77
1.3
1.5
—
—
—
0
0
29
134
2.20
3.77
1.3
1.5
—
—
—
0
0
29
134
2.20
3.77
1.3
1.5
—
—
—
0
0
29
134
2.20
3.77
1.3
1.5
—
—
—
0
0
85
554
1.59
3.76
2.4
2.8
73.73
71.19
e9/l
0.25
66
394
96
645
1.54
3.72
2.1
2.7
0.22
0.22
g/l
0.03
90
607
14
40
3.54
3.61
1.9
4.4
94.00
140.96
umol/l
—
6
23
100
684
1.52
3.58
1.4
1.3
149.40
240.41
u/ml
0.89
88
640
25
111
2.29
3.57
1.5
1.6
—
—
—
0
0
24
106
2.30
3.48
1.3
1.6
18.74
25.45
ng/l
1.15
24
106
238
1913
1.33
3.40
4.7
4.0
94.50
92.96
%
0.49
229
1866
45
254
1.81
3.39
1.1
1.3
—
—
—
0
0
24
109
2.23
3.27
1.2
1.3
—
98.72
—
0
8
235
1895
1.32
3.27
2.3
2.0
0.80
1.11
mg/l
2.27
186
1461
59
364
1.66
3.27
1.3
1.2
0.18
1.35
u/ml
—
9
23
19
82
2.34
2.92
1.5
1.3
—
—
—
0
0
259
2147
1.29
2.90
4.2
3.0
0.21
0.31
e6/l
1.17
189
1512
14
52
2.72
2.89
1.3
1.1
1733.71
1570.58
miu/ml
0.16
14
52
12
38
3.19
2.85
1.3
3.1
324.50
562.32
u/ml
1.59
12
38
57
363
1.61
2.83
1.6
1.9
3.49
6.58
iu/ml
—
10
89
42
247
1.73
2.80
1.7
2.2
1.35
1.32
g/l
0.07
31
221
33
181
1.85
2.77
1.8
1.8
177.88
197.99
pmol/l
0.50
33
169
120
897
1.39
2.73
2.9
2.9
8.17
6.85
umol/l
0.22
99
764
6
10
6.03
2.70
1.8
1.2
—
—
—
0
0
12
40
3.03
2.70
3.1
3.7
—
—
—
0
0
12
43
2.81
2.65
1.4
1.8
0.98
1.21
nmol/l
0.65
12
31
19
86
2.23
2.65
1.5
1.2
0.16
0.17
nmol/l
0.33
14
59
37
609
0.59
2.57
1.7
1.5
68.64
60.97
ug/l
0.44
32
516
12
42
2.88
2.55
2.3
3.2
81.25
137.36
nmol/l
0.70
12
42
15
62
2.44
2.55
1.1
1.1
—
—
—
0
0
248
2075
1.27
2.55
1.6
1.5
2.05
2.17
g/l
0.75
164
1320
6
11
5.48
2.54
1.0
1.1
—
—
—
0
0
166
1320
1.31
2.53
1.7
1.6
—
—
—
0
0
159
1257
1.32
2.52
1.4
1.4
420.80
538.04
titre
0.47
25
255
163
1296
1.31
2.48
3.7
2.7
0.77
0.91
e6/l
0.33
79
633
289
2468
1.25
2.48
4.3
3.1
29.34
95.96
e6/l
1.48
223
1824
344
2998
1.23
2.45
5.1
3.7
48.55
78.51
e6/l
0.80
233
1967
203
1665
1.28
2.44
3.5
2.5
4.18
7.18
e6/l
4.66
190
1499
272
3160
0.80
2.40
1.8
2.0
—
—
—
0
0
96
713
1.39
2.29
1.5
1.4
29.83
22.06
iu/l
1.03
82
595
6
13
4.64
2.27
1.3
1.8
1.41
1.25
umol/l
—
6
8
79
569
1.42
2.25
1.2
1.2
—
—
—
0
0
132
1034
1.32
2.24
1.2
1.2
—
—
—
0
0
283
2436
1.23
2.23
3.2
3.5
7.71
8.07
mmol/l
0.55
253
2122
9
29
3.12
2.23
1.8
1.3
2.11
0.67
u/ml
—
9
29
26
144
1.83
2.16
1.4
1.8
0.58
0.74
g/l
0.43
19
116
42
267
1.60
2.15
1.9
1.8
37.48
40.97
nmol/l
0.46
42
260
9
30
3.02
2.15
2.0
1.8
20.67
16.05
umol/l
—
9
30
899
8804
1.75
2.15
29.5
20.0
4.49
4.52
e12/l
1.28
893
8652
179
1469
1.27
2.14
4.0
2.7
556.56
537.16
mosm/kgh2o
0.58
159
1290
10
36
2.80
2.14
1.0
1.0
871.00
623.42
ng/l
—
5
26
29
167
1.76
2.13
1.1
1.3
4.23
5.60
u/ml
0.29
13
68
899
8806
1.74
2.11
29.6
20.1
6.84
6.75
e9/l
0.48
893
8648
767
7324
1.28
2.09
4.9
4.2
5.63
5.74
mmol/l
2.11
726
6856
57
398
1.46
1.94
1.4
1.5
16.07
9.34
u/l
0.44
48
317
8
27
2.98
1.94
1.1
1.4
183.88
88.53
ng/l
—
8
27
9
33
2.74
1.93
2.7
2.0
29.33
29.70
%
—
9
33
49
333
1.50
1.90
1.9
1.7
—
—
—
0
0
290
2547
1.20
1.82
4.4
3.3
16.01
78.10
ng/l
1.33
173
1505
35
224
1.58
1.78
1.5
1.3
236.14
324.27
ug/g
2.42
21
128
14
67
2.11
1.76
3.4
2.6
1.21
1.19
mmol/l
0.48
14
67
14
68
2.08
1.71
3.4
2.6
106.93
105.16
mmol/l
0.87
14
68
14
68
2.08
1.71
3.4
2.6
3.98
3.99
mmol/l
0.04
14
68
26
157
1.68
1.67
1.2
1.1
—
—
—
0
0
24
142
1.71
1.66
1.3
1.2
—
—
—
0
0
105
835
1.29
1.63
1.3
1.3
—
—
—
0
0
5
14
3.58
1.61
1.2
1.0
—
—
—
0
0
146
1215
1.24
1.56
3.9
2.9
3.54
2.85
e6/l
0.25
62
559
33
216
1.55
1.56
1.8
1.7
—
—
—
0
0
13
64
2.05
1.54
1.1
1.2
—
—
—
0
0
30
454
0.65
1.54
1.7
1.5
1.22
1.26
mm
0.18
22
332
307
3410
0.85
1.53
2.7
2.7
—
—
—
0
0
31
465
0.66
1.53
1.7
1.5
—
—
—
0
0
94
744
1.29
1.53
2.4
2.3
58.98
101.89
u/l
0.27
82
613
5
15
3.35
1.52
1.0
1.4
73.80
71.40
ug/l
—
5
15
81
1027
0.77
1.48
1.4
1.3
—
—
—
0
0
169
1438
1.21
1.47
5.0
5.1
19.36
2.29
ug/l
0.95
155
1302
7
28
2.51
1.45
1.3
1.6
—
—
—
0
0
36
245
1.49
1.44
1.3
1.4
0.19
0.42
nmol/l
5.17
26
204
5
16
3.14
1.44
2.2
1.2
—
—
—
0
0
237
2088
1.18
1.41
4.5
4.4
—
—
—
0
0
13
67
1.95
1.38
2.4
1.2
7.34
5.93
ug/l
0.16
13
58
27
174
1.57
1.38
2.4
2.7
1.20
1.84
index
0.42
15
95
16
89
1.81
1.38
2.4
2.4
—
—
—
0
0
16
89
1.81
1.38
2.4
2.8
—
—
—
0
0
38
265
1.45
1.36
1.5
1.3
—
—
—
0
0
11
54
2.05
1.33
1.5
1.1
10.73
8.26
mm/h
0.49
11
54
47
343
1.39
1.33
1.8
1.6
12.47
8.05
u/ml
0.32
18
89
33
473
0.69
1.32
1.7
1.6
—
—
—
0
0
11
55
2.01
1.27
1.3
1.4
28.06
26.01
umol/l
0.07
11
50
22
138
1.61
1.27
1.6
1.4
6.00
7.15
mmol/l
2.17
22
124
730
7037
1.18
1.24
5.7
5.3
37.24
37.90
mmol/mol
1.45
700
6707
115
960
1.23
1.22
1.5
1.4
—
—
—
0
0
96
786
1.25
1.22
1.2
1.3
134.83
152.41
u/ml
0.16
42
324
26
172
1.53
1.21
20.6
5.0
66.33
64.94
%
0.11
26
166
24
156
1.55
1.21
4.7
3.0
1.44
1.55
mmol/l
0.23
24
149
226
2008
1.17
1.21
3.3
3.6
60.95
49.95
mg/l
0.24
139
1335
293
2656
1.15
1.20
2.2
2.2
—
—
—
0
0
31
214
1.46
1.19
1.4
1.5
—
—
—
0
0
246
2203
1.16
1.19
1.9
1.8
—
—
—
0
0
41
300
1.38
1.16
8.3
5.5
24.76
24.70
mmol/l
0.08
41
288
229
2046
1.16
1.14
3.9
4.3
9.05
8.72
mg/mmol
0.04
135
1313
104
868
1.22
1.12
1.6
1.5
—
—
—
0
0
8
40
2.01
1.12
1.3
1.2
283.50
483.46
u/l
—
8
35
13
73
1.79
1.11
2.7
4.9
6.51
6.76
mmol/l
—
8
61
34
243
1.41
1.11
3.1
1.9
0.72
2.94
ug/l
1.15
28
220
191
1687
1.17
1.10
3.2
3.3
1313.27
1037.88
ng/l
0.35
148
1409
54
417
1.31
1.10
1.5
1.3
—
—
—
0
0
37
269
1.39
1.10
7.0
5.0
9.54
8.78
kpa
2.85
37
264
5
21
2.39
1.09
4.8
2.0
—
—
—
0
0
19
120
1.60
1.09
2.0
2.2
—
—
—
0
0
205
1823
1.16
1.09
1.9
1.9
—
—
—
0
0
7
32
2.20
1.08
1.4
1.2
184.86
94.73
nmol/l
—
7
22
31
219
1.43
1.08
1.6
1.3
232.31
227.17
u/ml
0.04
16
126
26
178
1.47
1.06
1.7
2.6
—
—
—
0
0
47
358
1.33
1.06
7.2
5.0
—
—
—
0
0
12
68
1.77
1.01
1.1
1.0
—
—
—
0
0
55
435
1.28
0.96
2.4
2.2
4.74
7.30
ug/l
1.23
47
390
83
991
0.82
0.95
1.2
1.2
—
—
—
0
0
20
133
1.51
0.95
2.9
3.3
3.82
4.25
e9/l
0.28
20
133
7
37
1.90
0.94
2.4
3.7
0.57
0.84
index
—
7
37
7
37
1.90
0.94
1.1
1.2
116.86
175.64
mmol/24h
—
7
37
30
218
1.39
0.92
1.1
1.1
6.87
7.56
u/ml
0.08
16
97
12
71
1.70
0.89
1.1
1.0
—
—
—
0
0
26
186
1.41
0.88
2.5
3.0
57.02
57.35
%
0.04
26
186
67
552
1.23
0.85
3.6
4.4
6.58
28.64
ug/l
0.81
47
440
52
416
1.26
0.85
12.2
10.8
1.18
1.34
%
0.69
52
411
12
72
1.68
0.85
1.9
2.9
1.13
1.35
g/24h
—
5
52
781
7627
1.15
0.85
4.7
4.4
4.65
4.66
mmol/l
0.10
750
7267
13
80
1.63
0.85
1.2
1.1
—
—
—
0
0
6
31
1.94
0.84
1.0
1.0
10.50
36.89
iu/ml
—
6
31
22
154
1.44
0.84
6.8
4.2
—
—
—
0
0
6
114
0.52
0.83
2.2
2.0
—
—
—
0
0
8
46
1.75
0.82
1.3
1.3
—
—
—
0
0
11
65
1.70
0.82
1.9
1.8
0.81
5.43
u/ml
—
6
21
63
519
1.23
0.81
1.3
1.2
—
—
—
0
0
52
422
1.25
0.77
1.1
1.1
—
—
—
0
0
18
124
1.46
0.75
5.3
3.2
6.46
7.60
mmol/l
2.03
18
118
12
75
1.61
0.75
1.0
1.1
—
—
—
0
0
6
110
0.54
0.72
1.3
1.7
—
—
—
0
0
127
1130
1.14
0.70
1.7
1.9
—
—
—
0
0
30
386
0.77
0.69
2.3
2.1
0.00
0.01
estimate
—
9
132
11
69
1.60
0.68
1.0
1.1
109.64
113.20
pmol/l
0.10
11
69
7
42
1.67
0.68
2.6
2.7
59.00
48.50
umol/l
—
7
37
26
196
1.34
0.68
5.4
4.3
1.35
1.37
mmol/l
0.07
26
190
19
136
1.41
0.67
2.8
2.5
190.66
113.16
ug/min
0.21
14
79
78
901
0.85
0.66
1.5
1.7
3.49
3.40
mmol/l
0.31
47
615
18
246
0.73
0.63
1.6
1.3
46.58
132.09
pmol/l
1.09
18
239
14
96
1.47
0.61
1.2
1.2
0.30
1.61
u/ml
—
8
34
10
152
0.65
0.61
3.1
3.3
26.20
26.65
mg/l
—
5
99
26
200
1.31
0.61
1.4
1.5
141.20
143.16
au/ml
—
5
59
145
1315
1.12
0.61
2.5
2.5
2.42
2.43
mmol/l
0.89
134
1176
60
510
1.19
0.60
6.7
4.6
7.42
7.41
ph
0.44
50
411
8
51
1.57
0.60
1.1
1.2
—
—
—
0
0
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
12
80
1.51
0.60
1.0
1.1
—
—
—
0
0
55
469
1.18
0.55
1.2
1.1
—
—
—
0
0
29
231
1.26
0.54
1.2
1.1
8.33
3.99
u/ml
0.37
17
113
22
169
1.31
0.53
1.2
1.1
—
—
—
0
0
18
134
1.35
0.53
2.3
2.6
1.82
2.35
mmol/l
0.88
11
84
9
64
1.41
0.51
1.9
2.1
-2.21
0.23
mmol/l
—
9
64
50
583
0.85
0.50
1.3
1.4
—
—
—
0
0
103
1140
0.89
0.50
1.8
1.8
3.69
3.42
ratio
1.14
70
851
7
109
0.64
0.48
1.1
1.2
20.44
14.45
u/l
—
7
92
13
93
1.40
0.48
1.3
1.1
0.44
2.08
u/ml
—
7
41
248
2624
0.93
0.48
3.0
2.2
—
—
—
0
0
34
283
1.21
0.45
4.0
4.3
226.86
294.92
mg/l
0.32
14
134
772
7602
1.09
0.45
4.6
4.3
1.45
1.47
mmol/l
0.70
739
7210
64
724
0.88
0.45
2.1
2.0
0.00
0.02
estimate
0.50
12
163
363
3779
0.94
0.44
12.2
10.1
0.00
0.00
e9/l
0.60
300
3081
80
891
0.89
0.44
1.4
1.4
—
—
—
0
0
7
51
1.38
0.44
2.3
3.5
1174.00
1137.53
mg
—
7
51
13
95
1.37
0.44
1.2
1.2
—
—
—
0
0
783
7718
1.09
0.43
5.3
4.8
2.74
2.76
mmol/l
0.22
752
7328
162
1509
1.09
0.43
1.6
1.6
—
—
—
0
0
8
56
1.43
0.42
1.0
1.0
—
—
—
0
0
74
663
1.13
0.41
3.9
4.7
0.62
0.62
%
0.00
26
179
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
78
702
1.12
0.41
4.1
4.8
1.00
0.96
%
0.05
29
197
21
168
1.26
0.40
1.1
1.2
—
—
—
0
0
37
432
0.85
0.40
1.4
1.6
0.16
0.30
mg/l
1.28
11
193
0
19
0.00
0.39
0.0
5.7
—
1.20
—
0
19
0
19
0.00
0.39
0.0
1.3
—
9.68
—
0
19
59
524
1.13
0.38
3.4
1.9
—
—
—
0
0
76
686
1.12
0.38
4.7
5.2
3.04
0.17
%
0.47
23
155
9
67
1.35
0.38
3.0
1.9
—
—
—
0
0
79
869
0.90
0.37
2.9
3.1
0.58
0.74
ug/l
1.89
49
528
20
163
1.23
0.34
2.5
2.6
—
—
—
0
0
26
219
1.19
0.33
1.1
1.1
—
—
—
0
0
17
137
1.25
0.32
1.9
2.6
7.78
7.23
pmol/l
0.11
17
137
26
220
1.19
0.32
1.1
1.1
—
—
—
0
0
728
7183
1.06
0.31
3.9
3.7
1.28
1.23
mmol/l
1.04
688
6778
7
100
0.70
0.30
2.9
3.6
39.54
3009.31
u/ml
—
7
91
59
650
0.90
0.30
1.8
1.8
—
—
—
0
0
65
708
0.91
0.27
4.9
3.4
—
—
—
0
0
16
132
1.22
0.26
1.4
1.3
—
—
—
0
0
245
2364
1.05
0.25
5.3
3.5
0.00
0.01
estimate
1.47
84
903
37
331
1.12
0.24
2.4
2.2
—
—
—
0
0
10
78
1.29
0.24
1.1
7.0
10.28
11.61
%
—
10
78
6
83
0.72
0.24
1.2
1.1
—
—
—
0
0
191
1835
1.05
0.23
2.5
2.6
302.51
324.37
umol/l
2.53
166
1653
31
275
1.13
0.23
1.1
1.1
—
—
—
0
0
5
40
1.25
0.22
1.2
1.1
329.00
189.54
iu/ml
—
5
40
0
10
0.00
0.21
0.0
3.2
—
0.23
—
0
10
0
10
0.00
0.21
0.0
3.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
56.00
—
0
12
37
407
0.91
0.20
1.1
1.1
1.53
1.55
g/l
0.15
37
407
29
323
0.89
0.20
1.3
1.2
0.28
3.82
u/ml
5.35
19
177
11
90
1.22
0.19
1.2
1.1
0.28
8.88
u/ml
—
6
26
281
2882
0.96
0.19
1.7
1.7
—
—
—
0
0
23
204
1.13
0.18
1.2
1.1
0.09
0.36
u/ml
1.01
12
64
38
414
0.91
0.18
1.1
1.1
0.91
0.88
g/l
0.50
38
414
7
63
1.11
0.17
1.0
1.3
—
—
—
0
0
61
649
0.94
0.17
1.8
1.8
—
—
—
0
0
27
244
1.11
0.16
2.8
2.5
4.68
6.06
umol/l
0.52
21
191
6
76
0.79
0.15
1.3
1.3
—
—
—
0
0
6
80
0.75
0.15
1.5
1.9
32.33
32.36
pg
—
6
80
62
656
0.94
0.15
1.8
1.8
—
—
—
0
0
26
237
1.10
0.14
1.3
1.2
—
—
—
0
0
30
276
1.09
0.13
1.2
1.1
0.52
1.65
u/ml
1.03
18
127
63
661
0.95
0.12
2.4
2.2
6.11
6.17
ph
0.16
44
441
32
297
1.08
0.12
1.2
1.2
—
—
—
0
0
31
288
1.08
0.12
1.2
1.1
3.09
6.15
u/ml
0.67
22
166
39
366
1.07
0.12
4.9
3.1
1.02
1.02
ratio
0.20
34
339
10
87
1.15
0.09
1.9
1.6
—
—
—
0
0
56
537
1.05
0.09
1.2
1.1
—
109.36
—
0
14
18
165
1.09
0.08
1.1
1.0
—
—
—
0
0
46
481
0.95
0.08
1.4
1.3
245.84
246.58
miu/ml
0.00
17
251
5
62
0.81
0.08
1.8
1.7
0.38
0.49
e9/l
—
5
62
5
65
0.77
0.08
3.6
3.4
60.00
55.59
%
—
5
59
7
65
1.08
0.08
1.0
1.2
—
—
—
0
0
63
652
0.96
0.08
1.8
1.8
—
—
—
0
0
6
71
0.84
0.07
1.2
1.1
—
—
—
0
0
109
1066
1.03
0.07
1.7
1.6
985.27
1022.58
mu/l
0.17
102
908
30
286
1.05
0.06
2.5
2.2
—
—
—
0
0
69
674
1.03
0.05
4.5
4.9
0.25
0.13
%
0.39
20
166
29
278
1.04
0.04
1.3
1.1
3.61
1.68
u/ml
0.52
18
149
12
113
1.06
0.02
1.1
1.0
—
—
—
0
0
11
106
1.04
0.00
1.5
1.5
—
—
—
0
0
15
154
0.97
0.00
1.0
1.1
2.02
2.31
eliau/ml
—
8
71
22
222
0.99
0.00
1.3
1.4
—
—
—
0
0
58
578
1.00
0.00
4.7
3.8
7.38
7.34
ph
2.09
42
424
10
101
0.99
0.00
3.0
3.6
1.50
1.08
%
—
10
93
25
247
1.01
0.00
7.0
8.3
—
—
—
0
0
57
573
0.99
0.00
1.6
1.7
—
—
—
0
0
60
605
0.99
0.00
1.8
1.9
—
—
—
0
0
11
105
1.05
0.00
1.1
1.1
10.38
16.40
u/ml
—
5
43
6
59
1.02
0.00
1.5
2.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
4.6
—
96.89
—
0
9
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
1.01
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
4.20
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
55
0.91
0.00
2.0
2.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
4.9
—
6.76
—
0
9
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
5
53
0.94
-0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
72.52
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
66
0.91
-0.00
1.2
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
78.58
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
19.18
—
0
6
7
77
0.91
-0.00
1.1
1.3
1.18
1.50
nmol/l
—
7
68

Mortality – FinRegistry

↥

Association

Association between endpoint H7_BINOCUMOVOTH and mortality.

Females

Parameter HR [95% CI] p-value
H7_BINOCUMOVOTH 1.212 [1.03, 1.43] 0.023
Birth year 0.996 [0.99, 1.0] 0.359

During the follow-up period (1.1.1998 — 31.12.2019), 225 out of 3488 females with H7_BINOCUMOVOTH died.

Males

Parameter HR [95% CI] p-value
H7_BINOCUMOVOTH 1.596 [1.34, 1.91] < 0.001
Birth year 0.986 [0.98, 1.0] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 292 out of 2306 males with H7_BINOCUMOVOTH died.

Mortality risk

Mortality risk for people of age

years, who have H7_BINOCUMOVOTH.

N-year risk Females Males
1 0.129% 0.356%
5 0.853% 1.789%
10 1.879% 4.371%
15 3.71% 8.414%
20 6.334% 13.823%

Relationships between endpoints

↥

Index endpoint: H7_BINOCUMOVOTH – Other disorders of binocular movement

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data